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Whole-genome sequencing projects have imparted much of the initial 
momentum for genome-wide studies, but it is microarrays and their application to 
cancer that has proved instrumental in establishing the power of the global view of 
genetics. Collections of global ‘microarray snapshots’ of the biological activity at 
molecular-level in the biological samples are now providing detailed 
characterizations and aiding in attaining an improved understanding of cancer. A key 
challenge now lies is in developing statistical and computational techniques that can 
extract biologically meaningful information from colossal amounts of data generated 
by the global transcription profiling studies. This thesis deals with developing two 
new methods to investigate the expression profiles of cancers. First, the existence of 
transcriptional bias in the regions of aneuploidy is addressed by showing pervasive 
imprinting of aneuploidy on the cancer transcriptome by reconstructing portraits of 
chromosomal aberrations using an individual tumor’s gene expression profile. A 
signal processing technique called wavelet transform is applied to a series of 
genomically arranged expression profiles to identify regions of coordinated 
transcription. These regions were subsequently shown to coincide with regions of 
aneuploidy. It is suggested that aneuploidy may contribute to tumor behavior by 
subtly altering the expression levels of hundreds of genes in the oncogenome. 
Second, a probabilistic methodology to construct a gastric cancer coexpression 
network is developed using genes that behave similarly across multiple datasets from 
disparate expression profiling platforms. The gene-gene coexpression interactions 
from different expression datasets of gastric cancer are systematically coalesced into 
 vii
a single unified coexpression interaction matrix. Subsequently a network is deduced 
and methodically explored at the level of network topology and functional modules. 
The cellular pathways and biological processes regulating the behavior of gastric 
cancer are described and its applicability to gene functional discovery is also shown 
through a case study. The methodologies developed in thesis, although, specific to 
gastric cancers, are applicable to other cancers as well.  
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 CHAPTER 1: INTRODUCTION 
 
Tumorigenesis especially in epithelial tissues is marked by the aberrant regulation of 
genes involved in cell proliferation, apoptosis, genome stability, angiogenesis, 
adhesion and cell-motility and metastasis (1). The key factors that have been 
implicated in driving deviant gene functions are changes in genome copy number, 
chromosomal translocations, epigenetic modifications, polymorphisms, point 
mutations, insertions-deletions etc. Well-known examples include- amplification of 
MYC (2) and ERBB2 (3), deletion of tumor suppressors such as PTEN (4), inherited 
mutations in BRCA1 and BRCA2 (5), translocation driven fusion of ERG-ETV (6) 
etc. Thus, cancer is a complicated disease, which surfaces in diverse cell types and is 
accompanied by various alterations in the DNA sequences. Many of these 
aberrations are specific to individual cancer types and produce molecular 
abnormalities that influence the expression of genes involved in tumor’s growth, 
ability to metastasize and response to treatments such as chemotherapy. The 
underlying genetic complexity has been difficult to study using traditional methods, 
which are best suited to investigating a handful of genes at a time. This complexity 
also has confounded the evaluation of new treatment approaches in oncology, since 
clinically homogeneous patient populations often represent molecularly 
heterogeneous patient subsets. 
 
1.1 Microarrays and Global Patterns of Tumor Gene Expression  
Cancer is a complex heterogeneous disease displaying varied cellularity, genetic 
modifications and clinical behaviors. Microarray technology has given researchers 
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the ability to rapidly measure the expression levels of tens of thousands of genes 
simultaneously in a biological system under investigation (7,8). Thus, by using 
microarrays coupled with statistical and pattern recognition techniques to detect 
similarities and differences among tumors, researchers have now been able to 
catalogue unprecedented amount of information about the changes that underlie 
different cancers (9). Consequently, mainstream cancer research has undergone a 
rapid metamorphosis following the induction of microarray technologies. The focus 
is rapidly moving from studying genes in isolation to large-scale or genome-wide 
studies involving simultaneous measurement of changes in thousands of genes, 
which in turn provides a more complete and somewhat unbiased view of the 
biological state of the cell. Although, these profiling experiments are broad discovery 
or exploratory studies but they are providing an invaluable resource for 
understanding basic biological processes and thereby aiding in the understanding of 
the cancer cell. Some examples are molecular subtyping of cancers (10-13), 
identification of diagnostic and prognostic markers (14-17), common gene functional 
and regulatory patterns shared by cancers (18,19), improving the sensitivity to detect 
new disease subtypes that can not be detected using standard biochemical assays and 
traditional light microscopy based approaches (20) etc. In conclusion, microarray is 
indeed a tool that has provided us with a high-throughput approach for understanding 
the cancer biology through systematic analysis of whole genomes and 
transcriptomes. 
 
1.2 Gastric Cancer 
Gastric cancer is a leading cause of cancer mortality worldwide, surpassed only by 
lung cancer (21). At present, the successful treatment and its prevention are plagued 
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by several clinical challenges. Most patients are presented at advanced stages, as 
there is currently no practical screening method for achieving early diagnosis. 
Therapeutically, only surgery confers a survival benefit (22) while chemotherapy is 
largely palliative (23). Despite a steadily declining overall incidence, the disease is 
still highly prevalent in the Asia-Pacific region, where it remains a major health-care 
challenge (24). A major difficulty in the diagnosis and treatment of gastric cancer is 
that very few of the currently utilized classification schemes are strong predictors of 
clinical behavior. Traditional classifications of gastric cancer on the basis of mucin 
content, histological architecture and cellular differentiation status are highly subject 
to inter-observer variation and are thus neither robust nor clinically meaningful (25). 
To date, only tumor staging is a proven prognosticator of gastric cancer (26). 
However, reliance on tumor staging alone is insufficient to fully sub-classify this 
disease, especially given the growing body of epidemiological evidences suggesting 
that gastric cancer is a complex disease whose pathogenesis is dependent on several 
genetic, clinical and dietary factors – 
I) Genetic factors: blood group A and parental history of gastric cancer (27), 
germline E-cadherin mutation (28) and DNA mismatch repair genes (29), 
polymorphisms in Interleukin-1B and the Interleukin receptor IL-1RN (30). II) 
Clinical factors: infections of helicobacter pylori (31) and premalignant gastric 
lesions (32). III) Dietary factors:  salt rich diets (33).  
In spite of these advances, relatively little is still currently known about the 
fundamental biology of gastric cancer, particularly when compared to other major 




The application of molecular diagnostics, in which the pathologic classification of 
tissues is based on a set of molecular and genetic markers, is a promising alternative 
to traditional techniques for the development of disease taxonomies that are clinically 
relevant. It is with this aim expression profiling of gastric cancers was conducted at 
our lab titled: A Combined Comparative Genomic Hybridization and Expression 
Microarray Analysis of Gastric Cancer Reveals Novel Molecular Subtypes (34). This 
study was successful in identifying novel molecular subtypes and genomic 
aberrations and discovered that gastric tumors could be grouped by their expression 
profiles into three broad classes: “tumorigenic,” “reactive,” and “gastric-like” with 
patients with gastric-like tumors exhibiting a significantly better overall survival. It 
laid the groundwork for the present research work by raising two main questions and 
this work attempts to answer them. First, no correlation could be observed between 
aneuploidy and change in transcripts level. Thus an unbiased methodology was 
needed to evaluate the effect of aneuploidy on the gastric cancer transcriptome. This 
work is briefly described in section-A below and detailed in Chapter 2. Secondly, 
several research articles were published describing the molecular subclasses of 
gastric cancer, but they lacked consistency among them. An analytical technique was 
needed to systematically combine the data on gastric cancers from disparate 
platforms. This work is briefly described in section-B below and detailed in Chapter 
3.  
 
A) No correlation could be observed between aneuploidy and change in transcript 
levels where as others (35,36) reported ambiguous results regarding the existence 
of a correlation between change in transcript level and the aneuploidy using 
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similar biotechniques. It was hypothesized that in the event of aneuploidy 
exerting a pervasive effect on gene expression, its effects should be ‘imprinted’ 
on the cancer transcriptome. Thus, an appropriate analytical tool was needed to 
reconstruct the portrait of chromosomal aberrations using an individual tumor’s 
gene expression profile. To ascertain if the aneuploidy profile could be 
reconstructed de novo from gene expression data, wavelet transform (37) based 
methodology was developed to identify regions of coordinated transcription 
within a target genome.  Wavelets can be thought of as small waves using which 
one can measure local or global topology by varying the scale and translating it 
along the signal. The continuous wavelet transform is known for its ability to 
accentuate the recurrent temporal patterns. It was thus applied to a series of 
genomically arranged gastric cancer cell line gene expression data followed by 
comparing the results to randomly arranged gene expression data to estimate the 
false discovery rate. Thus, using a combination of signal processing and 
statistical methodology, we identified several distinct regions of coordinated 
transcription. Interestingly, these co-regulated regions were more frequently 
observed in cell lines with large numbers of chromosomal aberrations. 
Comparing the above regions with chromosomal comparative genomic 
hybridization (CGH) data, a large majority (~80%) of these co-regulated regions 
could be specifically localized to a site of chromosomal aneuploidy. Also, up to 
47% of the total aneuploidy in the tumor cell lines could be directly inferred by 
this analysis without requiring apriori knowledge of the specific genomic 
locations of the chromosomal aberrations. The fact that the genome-wide portrait 
of tumor aneuploidy is constructible from gene expression data suggested that the 
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effects of chromosomal aneuploidy are pervasively imprinted on the cancer 
transcriptome. This work is described in Chapter 2.  
 
B) Several similar genome-wide studies on gastric cancer (38-40) appeared thereby 
providing insights into the molecular heterogeneity of gastric cancers. These 
studies showed that individual gastric tumors are indeed highly molecularly 
heterogeneous, and that in many cases, this heterogeneity is clinically significant. 
Poor consistency was observed between the molecular subtypes reported by us 
(34) and other groups (38-40). In each of the studies, preprocessed data were 
subjected to unsupervised learning techniques and the resulting molecular 
subtypes were reported on the basis of genes that clustered together. This led to 
inter-study discrepancies that could not be reconciled due to several confounding 
factors such as different patient populations and microarray platforms. A 
framework was needed that could combine data across multiple technology 
platforms. A probabilistic measure of coexpression interaction between a gene-
pair was derived based on the consistency of their correlation across multiple 
expression datasets. This was compared to a random case to compute the 
likelihood of a gene-gene correlation being random. To identify discrete 
molecular sub-networks, a novel clustering algorithm was developed to organize 
the significant gene-gene relationships into distinct ‘expression communities’. 
The topological properties of the network and the constituent modules were 
assessed to gain insight into the organization of information in gene coexpression 
networks. Four datasets comprising >300 tissue samples from four independent 
patient populations were subjected to the above methodology. Topological 
analysis of meta-network revealed a hierarchical scale-free architecture, with 
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embedded modularity. Several modules of distinct biological functions including 
protein biosynthesis, immune response, cellular proliferation, and gastro-
intestinal function were identified. These modules possessed distinct topologies: 
some (eg cellular proliferation) were integrated within the primary network, 
while others (eg ribosomal biosynthesis, digestive enzymes) were relatively 
isolated. Intriguingly, intestinal differentiation module exhibited a remarkably 
high degree of autonomy, suggesting that topological constraints may contribute 
to the frequent occurrence of intestinal metaplasia. Functional study of 
PhospholipaseA2 group IIA (PLA2G2A; gene of prognostic significance in 
gastric cancers, Ref 41) was carried out through analysis of genes in its 
coexpression neighborhood to reveal its association with WNT-signaling 
pathway. Thus, a methodology for systematic analyses at the level of network 
topology, functional modules, and constituent genes in gastric cancer was 
developed to identify cellular pathways and processes regulating the behavior of 
gastric cancer. It was used to identify a) systems-level features, and b) subtle but 
significant functional gene relationships relevant to gastric tumor biology. This 
work is described in Chapter 3.   
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Aneuploidy is one of the most frequently observed genetic aberrations in human 
cancers, and tumors with increasingly abnormal karyotypes (eg chromosomal 
amplifications, duplications and deletions) are often associated with greater 
aggressiveness, chemoresistance, and tendency for metastasis, suggesting a 
functional role for these genomic aberrations in shaping tumor behavior (1-3).  
Despite its ubiquitous nature, the specific effects of such large-scale chromosomal 
aberrations on the cancer cell, in particular the cancer transcriptome, remain 
controversial. For example, although certain groups have shown that alterations in 
DNA copy number can play a major role in determining a gene’s expression level (4-
8), others have reported that genes on regions of chromosomal amplification are 
rarely associated with increased expression (9). In addition, most of these reports 
have focused on specific regions, such as sites of recurrent chromosomal 
amplification (5,8-10) and may thus have been inherently biased. In order to resolve 
this issue and to understand the role of aneuploidy in the carcinogenic process, a 
systematic and unbiased genome-wide survey of the relationship between aneuploidy 
and cancer gene expression is required.  
We reasoned that if aneuploidy truly exerts pervasive effects on gene expression, 
then I) the effects of aneuploidy should be ‘imprinted’ within the cancer 
transcriptome, and II) with the appropriate tools, it should be possible to deconvolute 
an individual tumor’s gene expression profile to directly infer and reconstruct the 
specific portrait of chromosomal aberrations inherent to that tumor.  A major 
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difficulty in this regard is that the absolute expression levels of individual genes can 
vary tremendously, even when they localized in close physical proximity in the 
genome. Indeed, to our knowledge, there is no report that has successfully 
demonstrated that global gene expression information can be deconvoluted in a 
systematic and unbiased manner to derive a specific genome-wide de novo portrait of 
tumor aneuploidy.  To address this challenge, we developed a novel methodology, 
Wavelet Variance Scanning (WAVES), which employs wavelet transform signal 
processing algorithms to identify regions of coordinated transcription within a target 
genome. By applying WAVES to a series of gastric cancer cell lines, we identified 
several (>100) distinct regions of coordinated transcription, and found that these co-
regulated regions were more frequently observed in cell lines with large numbers of 
chromosomal aberrations. Remarkably, the large majority (~80%) of these co-
regulated regions could be specifically localized to a site of chromosomal 
aneuploidy, and up to 47% of the total aneuploidy in the tumor cell lines could be 
directly inferred by the WAVES analysis, without requiring a priori knowledge of 
the specific genomic locations of the chromosomal aberrations. Compared to 
methodologies relying on absolute gene expression levels, WAVES also appears to 
be a superior test for identifying regions of coordinated expression. This result has 
significant implications for cancer biology as it strongly suggests that aneuploidy 
does indeed act to drive pervasive and widespread gene expression changes 
throughout the cancer transcriptome. Our results confirm and extend previous reports 
proposing that aneuploidy may contribute to tumor behavior not just by affecting the 
expression of a few key oncogenes and tumor suppressor genes, but also by subtly 
altering the expression levels of hundreds of genes in the cancer genome. 
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2.2 Materials and Methods 
 
2.2.1 Cell Lines  
Gastric cancer cell lines SNU1, SNU5, SNU16, KATOIII, AGS, Hs746 and N87 
(Table 2.1) were purchased from the American Type Culture Collection (ATCC) and 
cultured according to ATCC recommendations.  
 
Table 2.1: Gastric Cell Line characteristics 
 
 Age Sex Origin Histology Cytogenetic Info 
SNU1 44 M Primary Tumor 
Poorly differentiated 
adenocarcinoma 
47, DM in 28%, 
hyperdiploid; 70; Y 
present 
SNU5 33 F Malignant Ascites 
Poorly differentiated 
adenocarcinoma 
tetraploid; 89; DM in 
16% cells 
SNU16 33 F Malignant Ascites 
Poorly differentiated 
adenocarcinoma 
tetraploid; 92; DM in 
12%, 4HSRs 
KATO III 55 M Pleural Effusion 




N87 NK M Liver Metastasis 
Well-differentiated 
adenocarcinoma 
near diploid; DM 
present in 64% cells 
Hs746 74 M Primary Tumor Not Known Not known 
AGS 54 F Primary Tumor 
Moderate-Poorly 
differentiated 47; range=39-92 
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 2.2.2 Comparative Genomic Hybridization(CGH) and Spectral 
Karyotyping(SKY)  
For CGH, tumor and normal (obtained from a healthy volunteer) genomic DNAs 
were cohybridized to metaphase spreads obtained from lymphocyte cultures of a 
normal individual (11). Ten to fifteen metaphase spreads were counted per slide. 
SKY was performed on metaphase slides prepared from each tumor cell line, using 
SKY Paint (Applied Spectral Imaging, Israel) (12), and analyzed by SKYview 
software (Applied Spectral Imaging, Israel). A minimum of seven metaphases were 
analyzed for each cell line. The complete CGH and SKY data is available in the 
Appendix to this chapter. 
 
2.2.3 Expression Profiling 
Total-RNA was extracted from cell line pellets using Trizol reagent and processed 
for hybridization to Affymetrix U133A Genechips following the manufacturer’s 
instructions. Each cell line experiment was replicated in triplicate. 
 
2.2.4 Mapping of Affymetrix Genechip Probes to the Human Genome Sequence 
We selected Genechip probes (19442) with an assigned Locuslink identifier 
(LocusID), using annotations from the Affymetrix web site (http://www.netaffx.com) 
and determined their corresponding physical location on the human genome using 
the NCBI Entrez Mapviewer database (www.ncbi.nlm.nih.gov/mapview/; June 
2003). Of 19442 probes with a LocusID, 8104 were localized to a unique LocusID, 
8470 were localized to 2-3 LocusID’s and the remaining 2868 to 617 LocusID’s.  
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2.2.5 Data Preprocessing 
Gene expression data was quality controlled by GeneData RefinerTM. Gene 
expression data from individual arrays were condensed using Affymetrix MAS5 
algorithm and subsequently normalized by median centering to 1000 expression 
units. For each cell line, the three replicates were averaged and the missing values 
were replaced by a nominal value of 1. Mean centering and normalization by 
standard deviation was also performed prior to wavelet transforms. 
 
2.2.6 Wavelet Transforms 
Wavelets are small waves with similarities to Fourier transforms, and are 
conventionally used to convert data from a time domain to a frequency domain 
(13,14).  Briefly, a wavelet is a function of zero average 
                                                        (1) ∫+∞
∞−
= 0)( dttψ
which can be dilated by a scale parameter ‘s’ and translated by a position parameter 






−= ψψ                                      (2) 
The wavelet transform of ‘f ’ which correlates ‘f’ with ψu,s at scale ‘s’ and position ‘t’ 





where * indicates a complex conjugate. By varying the wavelet scale ‘s’ and 
translating the wavelet along the positional index ‘u’, a plot of how the ‘Wf’ wavelet 
coefficients vary with scale and position can be generated. The transformation to 
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Fourier space provides a rapid way to calculate the coefficients at all translations for 
a given scale in one step (14,15).  
 
2.2.7 Continuous Wavelet Transforms and Scale Averaged Variance 
To estimate the continuous wavelet transform, the scales are dilated in powers of 2J 
(with J = 1 to 5 resulting in 2, 4, 8, 16, 32) with 4 logarithmic sub-divisions within 
each division. This range of scales was chosen based on an initial analysis of the 
relationship between wavelet variance density and scale, which revealed minimal 
variance beyond 25 (see Figure 2.1). Morlet Wavelets (15), which are gaussian 




)( τπψ −=     (τ = 6 to satisfy Eq.1)   (4)  
An estimate of wavelet variance at a given scale is obtained by summing the squares 
of the wavelet coefficients (the square of coefficients represents the variance). To 






V                                   (5) 
The square of the absolute value of the wavelet coefficients represents the variance 
and division by scale converts it into a variance density, subsequently refered to as 
‘wavelet-Gene Expression’ values. 
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Figure 2.1: Plots of wavelet variance density at various scales for N87, AGS and 
SNU1.  
 
To estimate the continuous wavelet transform, the scales are dilated in powers of 2J (with J = 
1 to 5 resulting in 2, 4, 8, 16, 32) using a morlet wavelet; with 4 logarithmic sub-divisions 
within each division. This range of scales was chosen based on an initial analysis of the 
relationship between wavelet variance density and scale, which revealed not much variance 
beyond 25. Wavelet variance density at each scale is plotted for three cell lines. The rest of 




 2.2.8 Wavelet Variance Scanning (WAVES)  
In WAVES, a moving window of ‘L’ probes (‘L’ is termed the scan length) is slid 
continuously over a wavelet variance matrix consisting of the scale averaged 
wavelet-Gene Expression values (Eq. 5) of all cell lines in the data set. Within each 
window, the most dominant cell line is defined by Ni (i ∈ [1,7]), the dominance 
value. ‘Ni’ refers to the number of times a particular cell line exhibits either the 
highest wavelet-Gene Expression value (for amplifications) or lowest wavelet-Gene 
Expression value (for deletions) in that window. It should be noted that in this 
particular implementation, only those regions unique to a particular cell line would 
be strongly elucidated. If a region is present in multiple cell lines, this methodology 
will result in one cell line being preferentially emphasized over the others.  
2.2.8.1 Definition of Dominance Causes Underestimation of Regions Scored 
Significant 
Due to our current implementation of WAVES, only a single dominant cell line is 
identified per genomic locus. As an example, we look at deletions in the 1pter:1p31 
region (~70Mb; covering 10 bands in 440 band CGH). Three cell lines N87, SNU5 
and KATOIII (left to right) have quite discernible deletions from CGH in this region 
as shown in Figure 2.2A.   
We look at the wavelet-Gene Expression values in the above region where three cell 
lines show a deletion in the chromosomal region 1p36.1:1p34 and visually interpret it 
in context of available CGH data (Fig. 2.2B).  
On plotting the dominance frequencies for chromosome 1 (Fig. 2.2C), we observe 
the following regions called significant by WAVES. Only one cell line (SNU5) is 
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identified as possessing a CORE in Region B (1p36.1:1p34), even though N87 and 
KATOIII harbor a deletion in this region as well (and show low wGE values in this 
region, Fig 2.2B). Hence, our definition of dominance in the current implementation 
of WAVES results in an underestimation of the regions deemed significant. 
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 Figure 2.2: Definition of dominance causes underestimation of regions scored 
significant 
 
(A) CGH profiles of 3 cell lines for region covering 1pter:1p31 region. CGH profiles of three 
cell lines N87, SNU5 and KATOIII are shown for chromosomal arm 1p. Each of the green 
and the red lines correspond to a 25% increase or decrease in the copy number respectively. 
















(B) Wavelet-gene expression values corresponding to 1pter:1p31 region. The genomically 
arranged cell line data are subjected to continuous wavelet transformation followed by scale 
averaging. The X-axis is the genomic location and the Y-axis is the wavelet-gene 
Expression. The cell lines show a marked decrease in the wavelet-gene Expression values at 
different genomic regions. It is seen that N87 (broken pink) has the most significant deletion 
in Region A (1p36.3:1p36.1), SNU5 (broken red) in Region B (1p36.1:1p34) and KATOIII 
(broken yellow) in Region C (1p34:1p31) although each deletion is spread out much more 
over much larger regions (see corresponding solid lines). 
B) 
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 (C) Plot of dominance frequencies for chromosome 1 for cell lines N87, SNU5 and KATO 
III. The X-axis is the genomic location and the Y-axis is the dominance frequency. SNU5 is 
identified as possessing a CORE in Region B (1p36.1:1p34), even though N87 and KATOIII 
harbor a deletion in this region as well. 
 
C) 









2.2.9 Confidence Assessment Using Random Permutations   
For each cell line, a statistical confidence value is attached to each region of high Ni. 
Since the null distribution of this data is not known, we empirically approximated the 
null distribution by simulating it under conditions where the gene order is randomly 
permuted. This was done by generating 100 randomly scrambled genomes and then 
subjecting them to wavelet transformation, followed by conversion to dominance 
space. For each of the 100 simulations, 19442-L windows are observed for each cell 
line. The mean of the 99th percentile cutoffs from the 100 random genome analyses 
( rndiN ) is taken as an estimator of the 99
th percentile value in the permuted data. 
Windows in the actual genome scan having Ni  ≥ rndiN  (i.e. above the permuted 99th 
percentile cutoff) are called significant at p ≤ 0.01.   
 
2.2.10 Estimating False Discovery Rates for Individual Cell Lines 
In addition to the Type I confidence values ascribed to each region of high Ni, it is 
also important to interpret these regions in the context of overall accuracy, based 
upon the total set of significant windows for each cell line. Thus, we have also used 
the false discovery rates to estimate the proportion of false positives from the total 
number of ‘significant’ windows (16). Using the rejection region fixed at the 99 
percentile from the random simulation results (see previous section), the false 
discovery rate of windows in the rejection region is defined as FDR = rndwiN / Nwi, 
where Nwi = the number of windows in the actual genome scan with Ni  ≥ rndiN , and 
rnd
wiN = 0.01 * (19442 – L) (the number of windows in the random data above the 
99th percentile value).  
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2.3 Results 
2.3.1 Wavelet Transformations of Gene Expression Information  
Wavelet transforms are signal-processing algorithms similar to Fourier Transforms 
that are used to convert complex signals from time to frequency domains. However, 
unlike Fourier Transforms, wavelets are able to functionally localize a signal in both 
time and frequency space, thus allowing transformed data to be simultaneously 
analyzed in both domains (frequency and time). We hypothesized that wavelet 
transforms might provide an effective means to identify genomic regions of 
coordinated transcription within an mRNA expression profile, due to their ability to 
accentuate recurrent temporal relationships between neighboring data points (17). To 
test this hypothesis, we applied the continuous wavelet transform procedure to 
genomically ordered transcription data derived from seven different gastric cancer 
cell lines. The wavelet transform maps the absolute gene expression levels in an 
expression profile to a new data set where the absolute variability is represented as 
wavelet coefficients across different scales and locations. This can be represented as 
a 3D graph that depicts the wavelet variance as a function of scale and location. An 
example of this process is illustrated in Figure 2.3A, where the gene expression 
levels of array probes ordered along chromosomal region 17q are resolved over both 
multiple scales and genomic location for cell lines N87 and AGS. Since this 
operation essentially converts absolute gene expression levels to their wavelet 
counterparts, we will henceforth refer to the wavelet variance value of a particular 
array probe as a “wavelet-Gene Expression” value. To address the challenge of 
interpreting data over multiple disparate wavelet scales, we also performed a scale-
averaging operation of the wavelet-Gene Expression data, where the individual 
variances were integrated over different scale ranges (see Methods). The resultant 
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scale-averaged data provides a representation of coordinated transcriptional behavior 
at a particular genomic locus. The effects of the scale averaging operations are 
shown in Figure 2.3B, for the same 17q genomic region – Narrow wavelets (small 
scale-ranges) uncover sharp features (top panel), while wide wavelets (large scale-
ranges) uncover more global features, by “flattening” the peak through distribution 
of the wavelet variance over a larger region (bottom panel). These results indicate 
that continuous wavelet transforms can be successfully applied to gene expression 
data, and that averaging of wavelet-Gene Expression values over smaller scale 
ranges captures local trends while averaging over larger scale ranges captures long-
range trends. 
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Figure 2.3: Wavelet transformations of gene expression data.  
 
(A) Normalized gene expression values for microarray probes localized to the 17q 
chromosomal region for all seven gastric cell lines (top), and wavelet transformed gene 
expression (wavelet-Gene Expression) data for the cell lines AGS (bottom right) and N87 
(lower left). The axes on the 3-D graphs represent genomic location, wavelet scale, and 
wavelet-Gene Expression values (“wavelet variance”). Cell line N87 displays a 17q12q21 
amplicon (red arrows).   





 (B) Scale averaged 2-dimensional wavelet-Gene Expression data for all seven cell lines, 
using narrow (top) and wide (bottom) scale wavelets. Narrow wavelets (small scales) 
uncover sharp features and local trends, while broader wavelets (large scales) are more 





2.3.2 Targeted Analysis of Regions Exhibiting Coordinated Gene Expression 
Suggests a Correlation with DNA Amplifications and Deletions 
As continuous wavelet transforms emphasize patterns of recurrent behavior, a 
genomic region exhibiting either a high or low wavelet-Gene Expression value 
indicates that the transcriptional behavior of genes in that region is occurring in a 
coordinated fashion. We refer to such regions as ‘COordinated Regions of 
Expression’, or COREs. Each of the seven gastric cancer cell lines displayed a 
unique wavelet profile, comprising several distinct COREs of high or low scale 
averaged wavelet-Gene Expression values relative to the other cell lines (usually 
spanning 100-200 ordered array probes, and 600-700 probes for some regions). We 
hypothesized that these COREs might correspond to sites of chromosomal 
aneuploidy, as the cell line N87, which carries a chromosomal amplification of the 
17q12q21 region (18, also see Appendix 2.6. for a more detailed examination of this 
region in the cell lines), also exhibited a higher wavelet-Gene Expression variance at 
this locus compared to the other cell lines (see Figure 2.3). To test this possibility, we 
manually identified several COREs and found that most of them could be localized 
to sites of chromosomal aneuploidy, as assayed by CGH or SKY. An example is 
shown in Figure. 2.4, which depicts the seven cell lines plotted by their wavelet-
Gene Expression values across Chromosome 7. Here, an extended region of high 
wavelet-Gene Expression variance was observed for cell line SNU5, as well as a 
region of low wavelet-Gene Expression variance for the cell line N87 (Fig. 2.4A). 
Indeed, as confirmed by both CGH and SKY, cell line SNU5 possesses a 
Chromosome 7 amplicon while the cell line N87 has a deletion of chromosome 7q 
(7q22qter; Fig. 2.4B for CGH and Fig. 2.5C for SKY). These results suggest that a 
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correlation may exist between COREs and sites of aneuploidy in gastric cancer cell 
lines.  
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 Figure 2.4: Correlation of wavelet-Gene Expression values to specific chromosomal 
aberrations.  
(A) wavelet-Gene Expression profiles of all seven gastric cancer cell lines for array probes 
localized to Chromosome 7 (X-axis). The wavelet-Gene Expression values (Y-axis) are 
presented on a log-transformed scale to highlight regions of both high and low wavelet 
variance. The cell line SNU5 exhibits several peaks of increased transcriptional co-
regulation in this region (red arrows), while the cell line N87 exhibits a region of decreased 





(B and C) Detection of Chromosome 7 aberrations in the cell lines SNU5 and N87 by CGH 
(B) and SKY (C). The majority of Chromosome 7 is amplified in cell line SNU5 (B, green 
lines in left panel), while the distal end is deleted in cell line N87 (B, red lines in right 
panel). Pink numbers refer to the total number of metaphase spreads counted. Similarly, 
SKY analysis reveals multiple copies of chromosome 7 in SNU5 cells (C, beige staining 
regions on top panel), while the distal end is deleted in N87 cells (C, pink arrow on bottom 
panel, a normal chromosome is shown on the right). The actual DAPI-stained metaphase 
chromosomes are shown to the left of the false-colored images. The SKY data is 
representative of 10-12 cells. 
 
B) N87 SNU5 




SKY (Chr 7) 
32
 2.3.3 WAVES – a Systematic and Unbiased Methodology for Identifying 
COREs  
The identification of COREs by manual inspection is highly laborious, prone to inter-
observer bias, and does not provide any statistical likelihood of such regions truly 
existing within a particular cell line (rather than being false positives). To definitely 
establish the suggested correlation between COREs and aneuploidy, we implemented 
a systematic and unbiased methodology to identify COREs on a genome-wide scale. 
Referred to as Wavelet Variance Scanning (WAVES), the absolute gene expression 
data from every cell line is subjected to a continuous wavelet transform, scale-
averaged, and combined into a wavelet transformed gene expression matrix (wavelet-
Gene Expression matrix) (Fig. 2.5). Next, a moving window of scan length L is 
continuously shifted over the wavelet-Gene Expression matrix, and within each 
window the ‘dominance frequency’ (Ni) of each cell line is recorded to form a 
dominance matrix (Fig. 2.5A, left panel). Depending upon the desired comparison, 
the dominance frequency is defined as the number of times a cell line either exhibits 
the highest wavelet-Gene Expression value compared to the other cell lines within a 
window (for amplifications), or the lowest wavelet-Gene Expression value (for 
deletions).  
To evaluate the significance of a dominance frequency Ni for a particular cell line, 
we empirically estimated the probability that a dominance frequency greater or equal 
to Ni would be observed by random chance by comparing the actual results to 100 
randomly permuted genomes where the probe locations were randomized (Fig. 2.5A, 
right panel). For each cell line, the mean of the 99th percentile values ( rndiN ) from 
the 100 scrambled genomes was used to define a rejection region that was then 
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applied to the distribution of true dominance frequencies (Fig. 2.5A, Ranked 
Dominance). The use of this rejection region allows us to attach a true positive 
probability of at least 99% to regions in each cell line having a dominance frequency 
Ni ≥ rndiN .  However, as ‘19442-L’ hypotheses (the total number of windows) are 
simultaneously tested with no correction for multiple hypothesis testing, the 
probability of observing at least one false positive in this assay is almost one (1 – 
(0.99)J, where J = number of hypothesis found significant). The decision not to 
impose a specific control on the overall false positive rate was deliberate, to ensure 
maximal sensitivity and that all possible regions are detected. Instead, we defined a 
false discovery rate (FDR = rndwiN / Nwi,) (See Methods, Ref. 16) to provide an 
indication of the extent of false positives among the significant hypotheses (i.e. cell 
line regions where Ni ≥ rndiN ). A high false discovery rate for a cell line indicates 
that many of the significant hypotheses are likely to be false positives.  
rnd
iN
The performance of the WAVES algorithm is presented in Fig. 2.6. As scan length L 
is increased, both Ni and were observed to increase, but the increase in Ni was 
more dramatic (Fig. 2.6A and 2.6B for cell lines SNU5 and AGS respectively). 
Conversely, reducing the scan length resulted in Ni eventually converging to rndiN , 
an expected result as narrower windows would naturally de-emphasize regional 
patterns of coordinated behavior within an ordered genome in favor of local ‘noise’. 
The false discovery rates for all cell lines were also observed to improve with 
increases in scan length L (Fig. 2.6C and 2.6D), up until 100 probe units. In contrast, 
small changes in the scale averaging conditions had a minimal influence on the 
overall results on the false discovery rates (Fig. 2.6A and 2.6B).  
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An interesting biological correlation was observed when CORES from the different 
cell lines were globally compared in this manner. Specifically, when dominance was 
defined as the cell line exhibiting the highest wavelet-Gene Expression value, the 
lowest false discovery rates (and highest specificity) were observed in cell lines 
exhibiting large numbers of chromosomal amplifications (eg cell lines KATOIII and 
Hs746), while the largest false discovery rates (and lowest specificity) were observed 
for cell line SNU1, which carries comparatively few chromosomal amplifications. 
However, if dominance was defined as the cell line exhibiting the lowest wavelet-
Gene Expression value, the lowest false discovery rates were observed in cell lines 
exhibiting large numbers of chromosomal deletions (eg cell lines N87 and Hs746), 
while cell lines SNU1 and AGS, which carry comparatively few chromosomal 
deletions, exhibited large false discovery rates. This result suggests that I) a global 
correlation exists between the presence of COREs and sites of chromosomal 
aneuploidy, and II) that this correlation is sufficiently strong that it can be observed 
even under conditions where the whole genome is analyzed in an unsupervised 
manner.   
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Figure 2.5: Unsupervised detection of COREs.  
 
(A) Schematic of detection scheme. The Expression Matrix is transformed into a Wavelet 
Matrix, containing the ordered wavelet-Gene Expression data for all cell lines. The phrase 
‘ordered’ indicates that the array probes were aligned by their true chromosomal sequence. A 
moving window is applied to the Wavelet Matrix, and within each window’s scan length, the 
frequency of a particular cell line exhibiting a dominant wavelet-Gene Expression value is 
computed. ‘Dominance’ can be defined as a cell line exhibiting either the highest (for 
amplifications) or lowest  (for deletions) wavelet-Gene Expression value compared to other 
cell lines. The ‘Dominance Matrix’ summarizes the dominance frequencies across all cell 
lines and windows. For any specific cell line, the distribution of dominance frequencies is 
compared against randomized data generated from an Expression Matrix where the probe 
locations were permuted. Dominance frequencies in the ordered data that exceed the 99th 
percentile of frequencies in the permuted set are deemed significant (arrowhead).  
 
(B) Graphs of dominance frequencies in ordered data compared to permuted data. The X-
axis represents either the moving windows as they occur along the ordered genome (left 
graph), or in the permuted genome (right graph). The Y-axis displays the dominance 
frequencies of the cell line KATOIII when an ordered genome is used (left graph), compared 
to a permuted genome (right graph).  The red arrow represents the 99th percentile dominance 
frequency in the permuted data, as averaged across 100 permuted simulations. Peaks in the 







 Figure 2.6: Performance characteristics of detection methodology. 
 
(A) and (B) Effects of varying Wavelet Scale and Scan Length of the moving window. 
Dominance frequencies were calculated for ordered (solid lines) or permuted  (dotted lines) 
genomes in two cell lines, SNU5 (A) and AGS (B). The Y-axis represents the 99th percentile 
value of dominance frequencies, and the X-axis the scan length of the moving window from 
25 to 150, using incremental steps of 25. Results from permuted genomes were averaged 
from 100 independent permutations, with scale bars representing ±1σ. Dominance 
frequencies were calculated using a morlet wavelet of either Scale-averaged Wavelets of 2-8 
(red lines) or 2-16 (blue lines). The dominance frequencies of ordered and permuted data are 





(C) and (D) False discovery rates (FDR, Y-axis) as a variation of scan length for all cell lines 
(X-axis). An FDR of 0.1 indicates that 10% of the dominance frequencies in the ordered data 
set are also observed in the permuted data set above the 99% percentile. FDRs are observed 
to decrease with increasing scan length sizes for all cell lines. Upper panel: dominance is 
defined as the cell line having the highest wavelet-Gene Expression values. The highest 
FDRs are observed for cell line SNU1, which exhibits the lowest number of overt 
chromosomal aberrations, while low FDRs are generally observed in cell lines with high 
numbers of chromosomal amplifications (cell lines KATOIII, Hs746). Lower panel: 
dominance is defined as the cell line having the lowest wavelet-Gene Expression values. The 
lowest FDRs are observed for cell lines carrying large numbers of chromosomal deletions 
(N87 and Hs746), while cell lines SNU1 and AGS, which carry few chromosomal deletions, 


































2.3.4 Global Concordance of COREs with Chromosomal Aberrations  
To definitely establish that individual COREs can indeed be used to directly infer 
specific sites of chromosomal aneuploidy, we performed a global concordance study 
between the CORE predictions and the CGH data. When dominance was defined as 
the cell line exhibiting the highest wavelet-Gene Expression value, four cell lines 
(SNU5, KATOIII, Hs746 and AGS) exhibited low false discovery rates of less than 
0.2 (Fig. 2.6C). For these four cell lines, 63 COREs were collectively found to be 
significant by WAVES, and of these 47 regions (or 75%) could be localized to 
regions of chromosomal amplifications, even though the COREs were initially 
identified without a priori knowledge of the locations of any chromosomal 
aberrations. Conversely, if dominance was defined as the cell line exhibiting the 
lowest wavelet-Gene Expression value, five cell lines (SNU5, KATOIII, Hs746, N87 
and SNU16) exhibited low false discovery rates of less than 0.2 (Figure 2.6D). For 
these cell lines, 76 COREs were collectively found significant by WAVES, out of 
which 65 (or 86%) were indeed located within regions of genomic deletion. Some 
examples are provided in Figure 2.7.  
In summary, approximately 80% of COREs identified by WAVES could be localized 
to confirmed sites of chromosomal amplifications or deletions, confirming that 
WAVES-identified peaks are indeed highly specific in their association with regions 
of chromosomal aneuploidy. Regarding the sensitivity of WAVES in identifying 
sites of known chromosomal aberrations, of 291 bands scored as significantly 
amplified by CGH (in the four cell lines with low false discovery rates, FDR < 0.2), 
146 (or 50%) could be associated with a CORE. Similarly, of 450 bands scored as 
significantly deleted by CGH (in five cell lines having low false discovery rates, 
FDR < 0.2), 205 (or 46%) could be associated with a CORE.  Thus, in total, 
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approximately 47% of the total chromosomal aneuploidy observed in these cell lines 
could be directly inferred from the WAVES analysis. We note, however, that the 
figure of 47% is almost certainly a lower limit and the actual figure is likely to be 
much higher. This is because the current implementation of WAVES was designed to 
identify CORES that are unique to each cell line, and thus aneuploid regions that are 
commonly present in multiple cell lines would have been missed. The detailed 
explanation for this has been provided at the Methods section 2.2.8. 
 
 41
Figure 2.7: Genome-wide association of COREs with chromosomal amplifications 
and deletions.  
 
The X-axis corresponds to moving windows ordered along the human genome, the Y-axis 
the dominance frequencies of the cell line, and the red line the 99th percentile dominance 
frequency derived from the permuted genome simulations.  
 
(A) and (B) Association of transcriptionally co-regulated regions with genomic 
amplifications detected by CGH for the cell lines SNU5 and KATOIII. Detected 
amplifications are indicated by their cytogenetic coordinates above each peak, and 
dominance is defined as the cell line exhibiting the highest wavelet-Gene Expression.  
 
(C) and (D) Association of transcriptionally co-regulated regions with genomic deletions 
detected by CGH for the cell lines SNU5 and N87. Detected deletions are indicated by their 
cytogenetic coordinates above each peak, and dominance is defined as the cell line 
exhibiting the lowest wavelet-Gene Expression.  
 
All significant peaks that can be matched to an observed chromosomal amplification or 
deletion are shown in black. Chromosomal coordinates in red type indicate a coordinated 
expression region for which a chromosomal aberration could not be detected by CGH. 
Chromosomal coordinates in green type indicate a coordinated expression region close to the 
centromere – the CGH data at these locations is not reliable due to the presence a large 






2.3.5 Performance Comparisons of Wavelet Transformed to Non-Wavelet 
Transformed Data  
Finally, we compare the performance of WAVES to a more conventional 
methodology where wavelet transforms were not performed. This is shown in the 
schematic below (Fig 2.8). We detect the regularity of high (or low) expression in 
genomic regions in a cell line when compared to other cell lines both in presence and 
absence of the WAVES procedure. Cell lines with minimal aberrations are chosen 
for this to check for the specificity of results emanating from the waves procedure.  
 
Figure 2.8: Schematic of the procedure used to compare the performance of wavelet 
transformed to non-wavelet transformed procedure.   
 
The WAVES procedure is applied to the genomically arranged transcription data and is 
compared to the corresponding results with no wavelet transform to look for extended 
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First, we compare the distribution of dominance frequencies of the wavelet and the 
non-wavelet transformed datasets for cell line AGS (Fig 2.9A and 2.9B). AGS has 1 
deletion, -18q, as detected by CGH and SKY. For non-wavelet transformed data, the 
99th percentile value from the 100 random simulations is 23.9 (σ = 0.72). In the 
actual genome, the number of windows having a dominance above this value (Ni = 
2404) results in an FDR of 0.08(193/2404), where the numerator represents the 
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number of windows in the random data with a dominance >23.9. In contrast, the 
wavelet transformed data under a similar situation gives an FDR ~ 0.57 (for L = 100) 
for regions called significant. This implies that majority of the regions called 
significant are potentially not significant. The WAVES thus provides a more realistic 
test.  
Secondly, we look at the distribution of dominance frequencies of the wavelet and 
the non-wavelet transformed datasets for the cell line SNU1 (Fig. 2.9C and 2.9D). 
SNU1 has 1 amplification, +20, as detected by CGH and SKY. For the non-wavelet 
transformed data, the mean 99th percentile value from 100 random simulations is 
52.7 (σ = 0.85). In the actual (unscrambled) genome, the windows having dominance 
above this value (Ni = 1645) gives FDR ~ 0.12 (193/1645). Wavelet transformed data 
under similar situation gives FDR ~ 0.37 (for L = 100) for regions called significant. 
This implies that majority of the regions called significant are potentially not 
significant.  
Thus, at similar levels of stringency, the conventional methodology was less specific 
and more prone towards identifying false-positive peaks than WAVES. Hence, 
WAVES appears to be a superior test for uncovering genomic regions harboring 
coordinated patterns of expression. Applying wavelet transform results in attaching 
better confidence values when trying to uncover genomic regions harboring aberrant 
patterns of expression. Wavelet transform bases procedure achieves this by 
accentuating relationship, if any, existing between the neighbors. 
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Figure 2.9: Distribution of dominance frequencies of the wavelet and non-wavelet 
transformed dominance frequencies for cell line AGS and SNU1.  
 
(A and B) Plot of the sorted dominance values for actual (blue) and a representative random 
(red) for non-wavelet (left) vs wavelet transformed dataset (right) are shown for cell lines 
AGS (top) and SNU1 (bottom). 99th percentile dominance value is marked by horizontal 








(C and D) Plot of dominance frequency for non-wavelet (left) and wavelet transformed 
(right) data for cell lines AGS (top) and SNU1 (bottom). Non-wavelet transformed data (left) 
reveals many regions of coordinated expression where as wavelet transformed procedure 




 2.4 Discussion 
 
In this chapter, we developed a novel methodology, WAVES, to explore the 
relationship between the cancer transcriptome and chromosomal aneuploidy. Central 
to WAVES is the use of wavelet transforms to identify genomic regions exhibiting 
coordinated transcriptional expression. Although others have also investigated the 
correlation between DNA copy number and gene expression, the strategy adopted by 
most of these previous studies has been to initially identify specific regions of 
aneuploidy or DNA copy number change, followed by examining genes within these 
regions for biases in gene expression (5,8-10). In addition, most of these reports have 
focused on chromosomal amplifications, and not deletions. In contrast, we believe 
that our study is the first to show that gene expression can be successfully used on an 
unbiased genome-wide scale to directly infer the locations of both amplifications and 
deletions in cancers, without relying on a priori knowledge of the locations of the 
chromosomal aberrations.  
Our study made several methodological and biological findings. First, we found that 
wavelet transforms are efficient at identifying regions of subtle but significant gene 
expression coordination in gene expression data. Previous applications of wavelet 
transforms in biology (13) have been in the analysis of genome sequences 
(identifying pathogenicity islands and long-range correlations between DNA bending 
sites) and protein structures (detection and characterization of repeating motifs). Our 
results indicate the wavelet transforms can be effectively applied to cancer 
expression data as well. Second, by applying WAVES to a set of gastric cancer cell 
line transcriptomes, we found that each cell line exhibited a distinctive profile of 
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COREs, supporting previous studies that every tumor (or cell line) is molecularly 
unique (19,20). Third, the number of COREs observed in each cell line was generally 
related to the number of chromosomal aberrations in that cell line, implying a 
relationship between the presence of CORES and the presence of genomic 
aberrations. Fourth, the majority of these expression regions (80%) could be 
correlated to a region of known chromosomal aneuploidy, as assayed by two 
independent methodologies – CGH, SKY. Reciprocally, up to 47% of the total 
chromosomal aneuploidy observed in the cell lines could be directly inferred from 
the gene expression data, and it is likely that this number is a lower limit (see below). 
The strong association between the presence of a CORE and a genomic aberration at 
that same genetic locus demonstrates that it is possible to directly infer the pattern of 
chromosomal aberrations for a particular tumor by studying its transcriptome. 
 Our finding that genome-wide portraits of tumor aneuploidy can be 
reconstructed from gene expression data strongly suggests that the effects of 
chromosomal aneuploidy are likely to be pervasively and globally imprinted 
throughout the cancer transcriptome. This is of significance as many researchers 
currently studying chromosomal aberrations in cancers have usually focused upon 
identifying a few key genes within the area of aneuploidy (5,8-9), under the 
hypothesis that these may represent important ‘driver’ oncogenes and tumor 
suppressor genes. Although this is likely the case for genes such as the ERBB2 
receptor on the 17q21 region (Ref. 21; more examples in Appendix section 2.6.3), 
our results suggest that aneuploidy may also contribute to tumor behavior by 
effecting subtle but wide-spread changes in gene expression at the level of hundreds 
and even thousands of genes. Others have reported similar results for selected 
chromosomal regions (4,7,22), and our study confirms these studies and extends their 
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validity to the entire genome. Although the absolute gene expression differences in 
the COREs are subtle, recent studies have also shown that subtle changes in multiple 
genes can lead to significant biological effects, particularly if these genes are 
associated with shared cellular programs (23). As such, we suggest that an important 
question for future research will lie in the development of methodologies that can 
address the possible phenotypic consequences of such subtle but significant patterns 
of transcriptional coordination. Some possible methodologies might include 
Metabolic Control Analysis (24) or Flux Balance Analysis (25), which have been 
successfully used in other scenarios to analyze complex phenotypes generated 
through the combinatorial interaction of multiple genes and cellular components. It is 
worth noting that a previous report, employing metabolic control analysis to study 
cancer gene expression data, has proposed that the large gains in metabolic fluxes 
observed in tumor cells are physically achievable only if one considers the 
contribution of thousands of marginally changing transcripts, which could arise in 
the context of chromosomal aneuploidy (26). This finding is consistent with our 
hypothesis that aneuploidy may contribute to tumor behavior not just by affecting the 
expression of a few key oncogenes and tumor suppressor genes, but also by subtly 
altering the expression levels of hundreds of genes in the oncogenome. 
Our study has several potential limitations. First and most importantly, in the current 
implementation of WAVES, only expression regions unique to a particular cell line 
are identified (see Methods section 2.2.8). This feature is almost certainly the reason 
why 55% of the CGH-aberrant bands could not be inferred from the gene expression 
data. Future versions of WAVES will contain enhancements to allow the 
identification of regions present in multiple cell lines. Second, we have focused in 
this study on the trancriptomes of cancer cell lines rather than solid tumors, and in 
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vitro data may not fully reflect a tumor’s in vivo behavior. However, a recent report 
has shown that the loss or gain of selected chromosomes in primary head and neck 
cancers is also strongly associated with alterations in gene expression over these 
large chromosomal regions (22). Third, the genomic aberrations in these cell lines 
were characterized using chromosomal CGH and SKY, and it is formally possible 
that these techniques, due to their low resolution, may have failed to detect small 
aberrant regions of the genome. However, a preliminary analysis correlating the 
chromosomal CGH results with BAC-array based comparative genomic 
hybridization data, which can detect more fine-scale aberrations (~1 Mb resolution), 
has revealed a high degree of concordance in the locations of the aberrations 
commonly detected by both technologies (data not shown).   
Finally, we suggest that in addition to cancer, WAVES could also be useful in 
studying other biological problems involving regional patterns of gene expression, 
such as various developmental conditions (eg Trisomy 21 in Down’s syndrome), or 
processes involving regional processes of transcriptional control (eg 
heterochromatin).  Previous reports have also shown that regions of coordinated gene 
expression can also be observed in a wide variety of non-malignant tissues and 
model organisms (27-30). Methodologies such as WAVES may thus represent useful 
tools in future efforts to generally understand how transcriptional information is 
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2.6 Appendix 
2.6.1 Spectral Karyotyping (SKY) Data 
 
Table 2.2: Spectral Karyotyping (SKY) Data 
 
SKY analysis was performed on metaphase slides prepared from each tumor cell line, using 
SKY Paint according to the manufacturer’s instructions (Applied Spectral Imaging, Israel). 
Briefly, whole chromosome paints for each chromosome labeled with different combinations 
of five fluorescent dyes were hybridized to the cell line metaphases, and the fluorescence 
emitted was passed through a Sagnac interferometer and captured digitally via a CCD 
camera. Analysis was performed using SKYview (Applied Spectral Imaging). A minimum 
of 7 metaphases were analyzed for each cell line and the composite karyotype is reported 




LINE COMPOSITE KARYOTYPE 
AGS 
46-50 [11], XX [11], der(8)t(1;8)(q31;p21) [11], der(10)t(8;10)(?;p13) 
[5], ider(13)(q10) [6], +14 [7], del(18)(q11.2) [6], -18 [5], 
+der(19)t(6;19)(?;13.3) [11], +20 [11] 
SNU1 47 [11], XY [11], der(4)t(4;1)(q31;q25) [11], +20 [11] 
N87 
42-43 [10], XY [10], +Y [8], der(1)t(1;5)(p32;?p) [3], +del(3p21) [4], 
+der(3)del(3p14;p24)ins(3;8)(p14;?) [5], der(4)t(4;11)(q13;q12) [6], 
der(5)t(5;19)(q10;p10) [4], der(6)t(6;14)(q10;q10) [10], del(7q22) [9], -
11 [7], -14 [10], der(17)t(17;22)(q21;q?) [9], -18 [10], der(21)del(21q) 
[7], -22  [10] 
SNU5 
68~92[7], X [4], der(X)t(X;15)(p10;q10) [5], del(Xq24)[3], 
der(1)t(1;8)(p32;?) X 2[7], -2[7], der(2)t(2;3)(p23;p26) X 3[7], +3[4], 
+del(4q21)[5], +der(4)t(4;13)(q31;q31)[7], +5q[4], +5 [4], 
+del(6q22)[6], +7 X 2[6], +der(7)t(7;3)(q31;p22) X 2[7], 
der(7)t(7;4)(q31;?) X 2[6], +8 X 2[4], +der(9)t(9;15)(q10;q10) X 2[6], 
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CELL  
LINE COMPOSITE KARYOTYPE 
+10[5], +11 X 3[7], +12 X 2[6], +dup13q22[5], +14[5], +16 X 2[6], 
+i(17q) [7], +19 X 2[7], +20 X 2[7], +21 [6], +22 [6] 
SNU16 
57~92[8], XX[8], +X[8], +1 X 2[6], +2 X 2[6], +3 [6] , 
+der(3)t(3;5)(q10;p10)ins(3;11)(q21;q13)ins(11;10)(q23;q24) [3], 
+der(4)t(4;21)(q10;q10)[8], +del(5q13)[5], +6 [5], +7 X 4[7],+8 [6], 
+der(8)t(8;13)(q10;q10) [4], +9 [6], +i(10p)[7], 
+der(11)t(1;11)(?;q10)[5], +11[6], +12q X 3[8], +13 [7], +14 X 2[8], 
+15 [6], +16 [7], +17 [7], +18 [8], +19[8], +20 X 2[7], +22 X 2[7] 
KATOIII 
77~84[12], XX[12], +X[12], +1[8], -2[4], +del(2q36) X 2[10], 
+der(2)t(2;12)(p10;?)[9], +3 X 2[10], +4[12], +6 X 2[11], +7 X 2[11], 
+der(7)t(7;11)(p10;q10)[10], +8 X 2[11], +9 [11], +10 [11], +11 [11], 
+der(11)t(11;10)(q14;q?) [11], +12 [8], +i(12q10) [3], 13 X 2[12], 
+14[10], +i(15q10)[12], +16 X 2[12], +17 X 2[12], +18 [8], +19 [11], 
+20 [12],  ider(20)dup(20q13.1)[12], +22 X 2[12] 
Hs746 
68~73[6], -X[2], der(X)t(X;3)(q25;?)[2], i(Yq)[2], 
+der(1)t(1;3)(p31;p12)[2], +3[4],  del(3)(q13.1)[4], 
der(3)t(3;8)(p21;q?)ins(3;21)(p14;q?)ins(2;3)(?;q13.1)[2], +5 [2], +6 
[5], +der(7)t(6;7)(?;q10) [2], -8 [2],  der(8)t(8;14)(q21.3;q12) [2], -
10[3], der(10)hsr(10)(q22) [4], -10 [3], +11 [2], -13 [2], 
+der(15)t(1;15)(?;q10) [2], +der(15)t(15;16)(q10;q10) [3], i(16q) [2], 
+der(17)t(6;17)(p10;q10) [2], +dup(22q)[3] 
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2.6.2 Comparative Genomic Hybridization Data for Gastric Cell Lines 
 
Figure 2.10 : Comparative Genomic Hybridization data for gastric cell lines 
 
Tumor genomic DNA (labeled with Fluorescein-12-dUTP) and normal genomic DNA 
(labeled with Texas Red-5-dUTP) were cohybridized to normal metaphase spreads obtained 
from lymphocyte cultures of a healthy volunteer. Image acquisition and analysis was 
performed using Cytovision ver 2.7 (Applied Imaging, Santa Clara). 10-17 metaphase 
spreads were counted per slide. Relative DNA loss and gains are shown in red and green bars 
(respectively) next to ideogram. Standard reference at 95% confidence intervals were used to 
detect the chromosomal gains and losses. CGH figures are available as : (A) SNU5, (B) N87, 



















 2.6.3 DNA Amplification and Expression Values for Known Oncogenes  
Several genes in 17q12q21 are known to be co-expressed and co-amplified in 
epithelial cancers. The N87 cell line exhibits a 1.5 fold DNA-amplification of the 
17q12q21 region, where the ERBB2 gene resides, and accordingly many of the genes 
in this region also exhibit increased gene expression, including ERBB2 which 
exhibits an increased expression level of 15-55 fold compared to the other cell lines. 
This result indicates that the ERBB2 gene is likely to be both amplified and 
overexpressed in the N87 cell line. The other cell lines do not display obvious DNA 
amplifications of the ERBB2 region, the closest being the SNU5 cell line, which 
exhibits a 1.25-fold genomic amplification for a small region of 17q21, and the 
KATO3 cell line, which displays a 1.25-fold amplification comprising the entire q 
arm of Chromosome 17. When compared on a single gene-by-gene level, all these 
other cell lines exhibited grossly comparable expression levels of genes surrounding 
the ERBB2 locus, indicating that the ERBB2 gene is unlikely to be highly amplified 
or overexpressed in these other cell lines.  
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Table 2.3 Gene expression levels of ERBB2 and surrounding genes in gastric cancer 
cell lines. 
Expression values are average of 3 replicates. Also, different probes mapping to the same 
Locus ID have been averaged into one value. Genes whose epression couldnot be measured 
are shown as ‘-‘. 
 
 AGS HS746 KATOIII N87 SNU1 SNU16 SNU5 
 ERBB2 764 217 500 11939 685 532 446 
 TOP2A 2188 2251 3121 3720 1949 2240 1387 
 PPARBP 572 392 653 4697 697 611 641 
 CRK7 320 244 344 2049 267 329 441 
 JUP 4237 - 3917 10638 - 4180 4769 
 MLN64 214 252 246 2222 283 235 262 




Data for some other cancer linked genes are also presented. Each cell line harbors a 
high level DNA amplification in the region of the known oncogene (or proto-
oncogene such as JUP, FRA1) when compared to other cell lines (See CGH results in 
previous section). Cell line N87 is 1.5 fold amplified at 17q12q21 (see previous 
page). Cell lines KATOIII and SNU16 are 1.5 fold amplified in the distal end of the 
chromosome 10 q-arm (other cell lines donot show any discernible ampplification). 
SNU16 has a 2 fold genomic amplification at the 8q24 band (KATOIII, SNU5 and 
N87 have 1.25, 1.5 and 1.75 fold genomic amplification respectively). Hs746 is 1.5 
fold amplified at 11p13 (SNU5 and KATOIII are 1.25 fold amplified) . SNU5 and 
HS746 are 4-fold and 2.25-fold amplified at the 7q31 (KATOIII and SNU16 are ~1.5 
fold amplified).  
 
Table 2.4 Gene expression levels of oncogenes and proto-oncogenes in gastric cancer 
cell lines. 
 
Expression values are average of 3 replicates. Also, different probes mapping to the same 
Locus ID have been averaged into one value. Genes whose epression couldnot be measured 





AGS Hs746 KATOIII N87 SNU1 SNU16 SNU5 
ERBB2, 17q21 764 217 500 11939 685 532 446 
JUP, 17q21 4237 - 3917 10638 - 4180 4769 
FGFR2, 10q26 376 59 5333 217 341 9648 - 
c-MYC, 8q24 3194 1108 1888 3009 2087 6347 3116 
FRA-1, 11q13 684 4259 1583 546 - 378 1057 
MET, 7q31 762 7918 1397 887 435 1102 8828 
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 CHAPTER 3: GENE COEXPRESSION META-
NETWORK OF GASTRIC CANCER 
 
3.1 Introduction 
Genome-wide expression profiling technologies such as microarrays and SAGE 
have contributed towards elucidating the molecular pathways of various cancers (1), 
the definition of molecular signatures for patient prognosis and treatment response 
(2-5), and the identification of new therapeutic compounds (6). In most previous 
studies, the processes of sample collection, processing, and data generation have 
typically been centralized and performed at single centers, to control for potential 
sources of technical variation such as surgical handling, experimental protocols, and 
histopathological scoring. Although successful, such single-center approaches can 
also be associated with possible limitations. For example, relying upon a single 
profiling platform can potentially introduce systematic errors of analysis (eg the 
mistaken genomic assignment of an array probe, or a particular data normalization 
protocol) that may impact downstream biological and clinical interpretation. More 
significantly, particularly for clinical studies, it is frequently difficult for single 
centers to amass sufficiently large numbers of tissue samples to robustly validate 
initial findings derived from smaller sample sets. Reflecting this difficulty, there are 
relatively few single-center studies in the biomedical literature where the number of 
profiled clinical samples has exceeded one to two hundred. In response to this 
challenge, there has recently been a growing interest in the use of meta-analytical 
approaches to analyze data from multiple data sets, to validate patterns of gene 
expression by examining their consistency of behavior across different studies (7). 
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However, in addition to validating known results, there is also the intriguing 
possibility that such meta-approaches could potentially play a powerful role in 
biological discovery by generating novel insights and biological relationships. 
Although some studies of this kind have been reported, most of these reports have 
typically focused on pooling expression data derived from a wide variety of tissue 
and tumor types (8,9). In contrast, comparatively fewer reports have specifically 
focused upon cancers from a single site of origin to investigate tissue-specific aspects 
of cancer.  
In this chapter, we present a systematic and comprehensive meta-analysis of the gene 
coexpression networks in gastric cancer, the second highest cause of global cancer 
mortality next to lung (10). To assemble a collection of clinical samples with 
sufficient breadth and diversity to characterize the gene expression interactions 
associated with this complex disease, we formed an international Gastric Cancer 
Consortium whose founding members, from Australia, Hong Kong, Japan, and 
Singapore had previously reported analyses of single-center gastric cancer data sets 
(11-14). We pooled the data from these independent studies to create a gene 
expression database of gastric cancer, comprising >300 human samples profiled at 
various histological stages of gastric tumorigenesis, ranging from normal gastric 
tissue, chronic gastritis, intestinal metaplasia, to overt carcinoma. Employing rank-
based statistics, we identified gene coexpression interactions conserved across the 
four centers and used these interactions to construct a consensus gene coexpression 
meta-network of gastric cancer (the “gastrome”). The resulting meta-network 
supports a scale-free hierarchical architecture, containing several deeply embedded 
functional modules associated with distinct biological functions. While some of these 
modules were previously known, other modules were previously unreported, 
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demonstrating the ability of the meta-approach to reveal novel biological 
information. The modules were diverse in their overall connectivity - some modules 
(eg cellular proliferation), were highly integrated with other modules, while others 
(eg ribosomal biosynthesis) were isolated and autonomous. Strikingly, a module 
associated with intestinal differentiation exhibited a remarkably high degree of 
autonomy, raising the possibility that the specific topological features of this module 
may functionally contribute towards the frequent appearance of intestinal metaplasia 
in gastric cancer. Finally, the gastrome analysis identified biological relationships 
that were less apparent from the single data sets – specifically, we found that 
Phospholipase A II group 2A (PLA2G2A), previously identified as a potential 
prognostic marker for gastric cancer (15), exhibited a conserved coexpression 
relationship with the EpherinB2 (EphB2) receptor and subsequently validated this 
association using tissue microarrays. Motivated by previous reports that EphB2 is a 
target of the Wnt signaling pathway, we obtained further experimental evidence that 
the Wnt pathway may also regulate PLA2G2A. Taken collectively, these findings 
demonstrate that meta-analytical approaches can successfully identify novel systems-
level features as well as subtle but potentially important biological relationships in 
tumor biology. Such strategies may thus prove useful and applicable to many other 
disease types, for the purposes of both biological validation and discovery.   
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3.2 Materials and Methods 
3.2.1 Gene Expression Datasets and Data Pre-processing 
The gastric cancer expression database derives from four independent studies (11-14) 
(Table 3.1 and 3.2). Each dataset was individually normalized, pre-processed, and 
deposited into a centralized server for further integration and pre-processing. 2252 
unique Unigenes overlapped between the four centers’ datasets. Multiple probes 
mapping to same Unigene were averaged after a log base 2 transformation of the 
data. Histopathological and clinical information associated with the tissue samples 
are described in the original reports and summarized in Appendix section 3.6.1. The 
expression data sets, collectively termed a ‘meta-dataset’, can be downloaded from 
http://www.omniarray.com/GCGC. The primary datasets are available at 






Table 3.1: Description of microarray datasets, data pre-processing and profiling 
platforms used for the four GC Studies 
 
Four populations of GC patients were expression profiled in 2002-03 at the Peter 
MacCullum Cancer Centre (Australia), Queen Mary Hospital, The University of Hong Kong 
(Hong Kong), RCAST University of Tokyo (Japan) and National Cancer Centre (Singapore). 
Each dataset was preprocessed in the research centers’ specific manner (Table 3.2) and 
deposited at a central server at RCAST, University of Tokyo. 2252 unique Unigenes 
overlapped between the four sets and multiple probes mapping to same Unigene were 
averaged after a log2 transformation.  
 
 












JP Affymetrix HU6800 6.8k 30 4560 
National Cancer 




 Table 3.2: Data generation and preprocessing details.  
 
 
Dataset Preprocessing Details 
AU 
 
The ratio metric is given by (Biological sample / Universal Reference). 
The Biological Samples are labeled with Cy5 (Green) and the Universal 
Reference RNA (Stratagene) is always labeled with Cy3 (Red). The 
arrays were scanned using a ScanArray 5000 scanner (Perkin-Elmer) and 
data extraction was done using Quantarray (GSI Lumonics). 
Subsequently, the data was imported into GeneSpring (Silicon Genetics) 
and intensity dependent LOWESS normalization was performed. The 
7383 genes were filtered using an intensity in the reference channel (Cy3) 
of 300. This corresponded to 2 standard deviations above the mean for the 
background signal. Background singal was calculated using the empty 
wells/spots on the array and the average of 4 different positions on the 
slide were used. 
 
HK 
The ratio metric is given by (Biological sample / Universal Reference). 
The Biological Samples are labeled with Cy5 (Green) and the Universal 
Reference RNA is always labeled with Cy3 (Red). The arrays were 
scanned using a GenePix 4000B scanner (Axon Instruments) and image 
processed using GenePix Pro3.0 (Axon Instruments). Areas of the array 
with obvious blemishes were manually flagged and excluded from 
subsequent analysis. The non-flagged array elements for which the 
fluorescent intensity in either channel was greater than 2.5 times the local 
background were used for subsequent analysis.  
JP 
The MAS5 algorithm was used for condensing, followed by scaling of 
expression values to have an average of 100 fluorescence units for each 
array. Subsequently, the expression value of each probe was divided by 
the average of 8 normal gastric samples. Thus, the ratio metric is given by 
(Biological sample / Average expression in normal gastric tissue). 
SG 
 
The ratio metric is given by (Biological sample / Universal Reference). 
The Biological Samples are labeled with Cy3 (Green) and the Universal 
Reference RNA is always labeled with Cy5 (Red). Two types of spots 
were excluded (a) Spots for which foreground intensity was lower from 
background by lesser than 10 fluoresence units (b) Spots that could not be 
identified reliably by the scanner (Arrayworx) software within the "region 
of interest" masked by the user. The 2 channels for each array were 
equalized by multiplying the reference channel Ch2(Cy5) by a constant 
which is derived by (Total Cy3 / Total Cy5). Subsequently, the expression 




 3.2.2 Identification of Conserved Coexpression Interactions 
For each dataset, we calculated Pearson correlation coefficients between every gene-
gene pair, and for each gene ranked all other genes (from 1 to 2251) by its correlation 
coefficient to the former, Rank 1 being the least correlated and rank 2251 the most 
correlated.  Notably, although the absolute correlation value of (A → B) = 
correlation (B → A), the rank of gene A with respect to gene B may not be the same 
as the rank of gene B with respect to gene A (see Apendix 3.6.2 for an example). To 
identify gene pairs exhibiting consistently high ranks across multiple datasets, we 
calculated the joint probability of observing a particular sequence of ranks: Briefly, 
for a random sample X of size ‘n’ drawn from a uniform distribution [1..N] (n= 4 and 
N = 2252 in this case), if the ‘n’ numbers are sorted such that X(1) and X(n) are the 
smallest and largest numbers respectively; then X(k) follows a beta distribution with 
parameters (k, n-k+1), and p(X(1),X(2),X(3),X(4)) or the joint probability ‘p’ of 
observing a sequence of ranks X(1),X(2),X(3),X(4) can be calculated as follows.  
Let Yk be the order statistic associated with ‘n’ independent observations X1 .. Xn. 
such that (Y1 < Y2 … < Yn). Each X is taken from a uniform distribution with the 
distribution function F(x) = x and mass function f(x) = F′(x) = 1  (0 < F(x) < 1 ). The 
event that the Yk th order statistic is at most ‘y’ (i.e. Yk ≤ y) can happen if and only if 
at least ‘k’ of the ‘n’ observations are less than or equal to ‘y’. Using the probability 
of at least ‘k’ successes the distribution function Gk(y) and probability density 
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 74
























                             (2) 
This resembles a beta distribution with parameters α,β with α = k and β = n-k+1.  
The joint pdf Y1 .. Y4 is thus p(Y1, .. ,Y4) = g1(Y1)* g2(Y2)* g3(Y3)* g4(Y4). Since, 
there are 4! ways of rearranging Xi’s to give Yk’s, we have,  
p(X1, X2, X3, X4) = 4! * g1(Y1)* g2(Y2)* g3(Y3)* g4(Y4)                         (3) 
p(X1, X2, X3, X4) = 4! * g1 (X(1)) * g2(X(2)) * g3(X(3)) * g4(X(4))             (4) 
Where X(k) is the kth smallest Xi  
The maxima of gk occurs at (y =0; y =1/3 ; y =2/3 ; y = 1 for k = 1,2,3,4 
respectively). We use these values to formulate our null hypothesis case.   
Since the X(k)’s correspond to an observed sequence of ranks for a particular gene 
pair (A,B) across the four datasets, we can define the null hypothesis H0 that for a 
gene pair (A,B) the sequence of X(k)’s or ranks is random, and the alternative 
hypothesis H1 that the observed ranks across the four datasets is non-random. Using 
a metric termed the ‘Log Likelihood Ratio’ (LLR) = log10 [p(H0)/ p(H1) ], H0 is 
rejected iff LLR ≥ LLRcrit, where LLRcrit is user-defined. As the LLR is based on 
ranks, LLR(A → B) ≠ LLR(B → A), hence we define LLR(A ↔ B) = Max { LLR(A 
→ B) , LLR(B → A) }, and two genes A and B are called “coexpressed” iff LLR (A 
↔ B) ≥ LLRcrit. Only 0.94% and 0.27% of possible interactions show a LLR 
difference greater than 1.5 and 2 between LLR(A → B) and LLR(B → A) 
respectively. The LLR score is also blind to gene pairs being positively or negatively 
correlated; thus this technique does not segregate on the basis of gene-pairs being 
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positively or negatively coexpressed. In addition to the LLR, a False Discovery Rate 
(FDR) was used to reflect the fraction of false positives present in hypotheses 
deemed significant above a given LLRcrit. To estimate the FDR, we generated 50 
randomly permuted meta-datasets where the rank order of the genes in the single-
center data sets were shuffled, and calculated the number of links found significant at 
a given LLR. This randomization process was then repeated 50 independent times 
and the results averaged. For a given LLRcrit, 
]H | LLR [LLR #




≥=                                                            (5) 
 
3.2.3 Clustering Coefficient 
The clustering coefficient (16) Ci of a node ‘i’ with ‘ki’ neighbors is Ci = 2*C/ki(ki -
1) where C is the number of connections between the ‘ki’ neighbors of node ‘i’. The 
Ci provides a quantification of the extent to which the coexpression neighbors of a 
gene are also connected to each other. The clustering coefficient for the network is 
given by ĈNo = 1/No ΣCi where ‘No’ is the number of nodes in the network with 
more than one coexpression partner. For comparative analysis of the clustering 
coefficient, we simulated “equivalent” scale free network. The simulated equivalent 
“pure” scale free networks is based on a previously described “preferential 
attachment” model (17), specifying the average number of connections per gene 
(kavg) and number of nodes with more than one coexpression partner (No). The links 
are non-directional and unweighted with no self-connection and no multi-
connections between two vertices. Starting with ‘mo’ number of vertices, a new 
vertex is attached to the ones already present during the course of iteration. The 
incoming vertex makes ‘m’ new links with the existing vertices. The probability of 
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the incoming vertex joining an existing vertex is proportional to the number of 
connections it (the existing one) already has. Thus, for a given value of No and kavg, 
an equivalent network is simulated using the above model with iterations stopping at 
No and each iteration having m = kavg/2. For cases like, LLR 8 (kavg ~ 5), the nearest 
integer is used (eg 3 for LLR 8 case instead of 2.5). A typical scale free simulation 
result is compared with the equivalent results from the coexpression network (Fig 
3.1). 
 
Figure 3.1: Simulating a pure scale free network using preferential attachment model 
 
P(k) (Y-axis, log scale) is the probability of a gene having ‘k’ expression links (X-axis, log 
scale). A simulated pure scale free network (squares) using the preferential attachment model 
and the coexpression network at LLR5 (circles) is plotted.   
   




  3.2.4. Assembly of Expression Communities and Functional Modules 
To generate expression communities, we identified all co-expressed gene pairs of 
Log Likelihood Ratio (LLR) ≥ LLRcrit and connected these genes by ‘chain-linking’: 
Assume Gene A’s maximal link occurs with Gene B, and Gene B’s maximal link is 
to Gene C (and not necessarily Gene A). Gene A is then connected to Gene B, and 
Gene B to Gene C. This process continues, forming a gene chain, until a terminator 
pair is encountered which is reciprocally maximally linked (i.e. Gene A Æ Gene B 
Æ … Æ Gene I ÅÆ Gene J). Chains of length >3 and which end in the same chain 
terminator pair are pooled to form a ‘scaffold’. The coexpression partners of the 
genes in the ‘scaffold’ are subsequently aggregated to form an expression 
community. Communities of size > Smin, where S refers to the number of genes, are 
considered for further analysis. To assess the similarity of any two communities, we 
calculated the probability of overlap: Two communities of gene sizes S and T are 
chosen out of N (2252 in this case), with the probability of the two groups having M 




MTSNCMSMNCMNC −−−−                                       (6) 
where C(X,Y) is the number of ways sets of size Y can be selected from a set of size 
X (X ≥ Y).   To assemble functional modules from the communities, we ranked the 
communities in order of increasing size. Starting with the smallest community; its 
highest overlapping community was identified and if 50% or more of the members in 
the former were also present in the larger community then the smaller sized 
community was merged with the larger. The above steps were repeated until all the 
expression communities were partitioned into distinct functional modules. To 
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confirm their modularity, we compared the numbers of internal to external 
expression links of each module to an equivalent number of randomly selected genes 
drawn from the original 588 gene set (see Results). Across 2000 runs, the modularity 
of the former always exceeded the random data, thus assigning an empirical p < 
0.0005. We note that in constructing the final network, all samples (non malignant 
and cancerous) were examined irrespective of phenotype.  
 
3.2.5 Hierarchical Clustering and Other Software Sources 
Average linkage hierarchical clustering was performed using an uncentered 
correlation similarity metric. Median centering by genes was performed prior to 
clustering each dataset.  Cluster and Treeview 
(http://rana.lbl.gov/EisenSoftware.htm) software were used for clustering and 
generating expression heatmaps. All other methodologies were implemented in 
Matlab (http://www.mathworks.com) and the network plots visualized using Pajek 
(http://vlado.fmf.uni-lj.si/pub/networks/pajek/). 
 
3.2.6 Construction of Gastric Cancer Tissue Microarrays 
A gastric cancer tissue microarray (TMA) was prepared using standard methods (18) 
(see Table 3.3 for clinical data associated with these arrays). The TMA included 343 
gastric cancers and 75 non-tumor gastric mucosa, of which 24 exhibited intestinal 
metaplasia. Briefly, paraffin blocks of gastric cancer derived from gastrectomy 
specimen were retrieved from the archives of the Department of Pathology, Queen 
Mary Hospital, The University of Hong Kong. For each case, an area of invasive 
carcinoma was identified under microscopy in the corresponding Hematoxylin and 
Eosin stained slide, and a 0.6 mm diameter tumor tissue core was punched from the 
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corresponding area of the paraffin block and transferred to a recipient block using a 
Tissue Microarrayer (Beecher Instruments, Silver Spring, MD). Tissue cores 
containing areas of non-neoplastic gastric mucosa, including those with intestinal 
metaplasia, were included when available. A small number of cases were eventually 
excluded from the study due to loss of tissue on the TMA, absence of cancer tissue 
on the histo-spot or poor RNA integrity as evident by absent in-situ hybridization 
signal using the β-actin riboprobe.  
 
3.2.7 Immunohistochemisty  
Villin1 (VIL1) expression was assessed using antibody ID2C3 (Immunotech, France) 
at a 1:200 dilution and streptavidin-biotin peroxidase after heat-mediated antigen 
retrieval. EphrinB2 (EphB2) expression was assessed using Goat anti-EphB2 (R&D 
Systems) at a 1:100 dilution and the DAKO EnVision+ System Peroxidase, (DAB) 
after heat-mediated antigen retrieval. EphB2 positive cells were stained primarily at 
the cell membrane. For EphB2 staining, the membrane staining intensity in each 
tissue core was graded as negative 0; weak 1; moderate 2; strong 3. A score of 0-1 
was considered EphB2 negative whereas a score of 2-3 was considered EphB2 
positive for categorical data analysis. In-situ hybridization (ISH) for PLA2G2A 
produced deep brown cytoplasmic staining for positive signals, and the staining 
intensity in cancer cells was graded as negative 0, weak 1; moderate 2; strong 3. 
Similarly, a score of 0-1 was considered PLA2G2A negative and a score of 2-3 was 
considered positive. Two independent observers performed the 
immunohistochemical grading, and cases with discrepancy were reviewed to arrive at 
a consensus. 
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Phospholipase AII group IIA (PLA2G2A) expression was assessed by non-
radioactive in-situ hybridization (19). Primers for generating the PCR-based 
riboprobe templates (minus T7 promoter sequences) were: PLA2G2A (forward) 
TTCTACGGCTGCCACTGTGG; (reverse) GGAGGAGAGCAGTAGAAGGC. A 
β-actin riboprobe (Roche) was used to ensure RNA integrity.  
For cell line experiments, a mouse monoclonal anti-β-catenin antibody (Transduction 
Laboratory, Lexington, KY) was used at 1:200 dilution. Gastric cell lines were 
cultured to 80% confluence, washed in PBS and fixed in 4% paraformaldehyde. 
Paraffin cell blocks were prepared. Immunohistochemical staining was performed 
using the DAKO EnVision+ system, peroxidase (DAB) after heat-mediated antigen 
retrieval. 
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 Table 3.3: Patient demographic data and expression of EphB2 and PLA2G2A in the 





  Male 
  Female 








  Range 




 66.5 ±12.9 
Tumor differentiation 
   
  Well 
  Moderate 







   
  Negative 
  Weak 
  Moderate 








   
  Negative 
  Weak 
  Moderate 











3.3.1 The Gastrome – A Consensus Gene Coexpression Meta-network of Gastric 
Cancer 
We combined microarray expression data from four separate studies encompassing a 
total of 302 patient samples reflecting different aspects of gastric cancer pathology, 
from normal mucosa, chronic gastritis, intestinal metaplasia, to carcinoma (Table 3.1 
and 3.2). Collectively termed a ‘meta-data set’, the four data sets were integrated as 
shown in Figure 3.2A. First, we identified 2252 common Unigene entities across the 
four datasets, and computed Pearson’s correlation coefficients for all possible gene 
pairs within each data set. For each individual gene, we ranked all other 2251 genes 
based on their strength of correlation to the former, producing for each data set a 
‘rank matrix’ of ~5x106 (2252 x 2252) pair wise ranks, and ultimately associating 
every gene pair (A, B) with a characteristic sequence of 4 ranks (one from each data 
set). For example, the rank order of PCNA with respect to TOP2A is [2224, 2230, 
2242, 2244], indicating that PCNA is the 28th, 22nd, 10th, and 8th most positively 
correlated gene to TOP2A across the four sets. To identify pairs of genes whose 
expression was significantly correlated and conserved, we applied a rank-based 
statistic to calculate the “log likelihood ratio” (LLR) for each gene pair, where a 
large LLR indicates a deviation from the null hypothesis (i.e. that the sequence of 
ranks associated with the gene pair is unlikely to be random). ‘Significant’ gene pairs 
(henceforth termed ‘expression links’) were defined as those whose LLR exceeded a 
user-defined cutoff (LLRcrit). To reflect the balance between sensitivity and 
specificity, we computed false discovery rates (FDRs) to estimate the proportion of 
false positive expression links associated with any particular LLR value – this was 
achieved by generating a series of randomly permuted meta-datasets where the gene 
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names within each individual data set were internally shuffled, and determining the 
number of links found to be ‘significant’ within the randomized data (see Methods 
section 3.3.2).  
The results of this procedure are shown in Figure 3.2B. First, we observed that at all 
LLR values > 0.5, the numbers of significant expression links in the actual data 
exceeded those in randomly permuted data. The gap between actual and random data 
increased at higher LLRs, reducing the FDRs and leading to higher specificity (Fig. 
3.2B, yellow triangles). For example, at LLRs 5 and 8, ~12.3k and 925 links were 
found to be significant, with associated FDRs of ~13% and ~1.6% respectively. This 
result indicates that a substantial number of expression links are indeed conserved 
across the different data sets, which are likely to represent bona-fide biological 
interactions. Second, we found that increasing the LLR cutoff caused the numbers of 
significant expression links to decrease at a greater rate than the numbers of 
individual genes (Fig. 3.2B), indicating that increases in specificity can be apparently 
obtained without incurring a similarly dramatic penalty in the absolute number of 
genes participating in the network. For example, increasing the LLR stringency from 
4 to 8 caused a 36-fold drop in the numbers of expression links (~33.5k to 925) but 
only a 3.7-fold reduction in the number of genes (~2.2k to 588). This result is 
consistent with the hypothesis that the majority of genes are associated with 
relatively few highly specific expression links, a concept that is further developed 
later on in this chapter. Third, to test if the significant expression links were robust or 
sensitive to the presence of particular sample types, we generated 10 randomly 
truncated meta data sets where in each 50% of the original samples were removed, 
and compared the significant links in each truncated set to those found in the original 
meta-data set. We found that at LLR ≥ 5, ~57% of the significant links in the 
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truncated datasets were conserved with the complete dataset, and that the 
conservation increased to ~64% at LLR ≥ 8 (corresponding FDRs are ~21.3% and 
~3.2%). This result suggests that the sample population used in this study is 
reasonably broad and diverse with respect to gastric cancer physiology, as the 
majority of the significant expression links are fairly robust to the presence of any 
particular sample type. We also checked the dependence of the expression links on 
the specific presence of non-malignant tissues, by removing the 70 non-malignant 
samples (including normal, chronic gastritis and intestinal metaplasia) and repeating 
the entire analysis. Despite the removal of non-malignant tissues, a similar result was 
obtained where ~56% of the expression links were conserved between the 
‘malignant-only’ and the complete dataset at LLR ≥ 5, increasing to ~61% at LLR ≥ 
8 (corresponding FDRs ~13% and ~1.5%), once again indicating their robustness. 
These results demonstrate that rank-order statistical approaches can be successfully 
used to identify conserved and robust gene expression interactions from multiple 
disparate data sets, despite the latter being derived from distinct patient populations 
and array technologies. Having identified these interactions, we assembled them into 
a gene coexpression meta-network of gastric cancer, termed the ‘gastrome’. We now 
analyze the gastrome in terms of its general topology, functional modules, and 
constituent genes. 
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Figure 3.2: Identification and distribution of conserved coexpression links.  
 
(A) General schematic for generating the coexpression meta-network (gastrome). The four 
datasets (SG, AU, JP, HK) were each truncated to 2252 common Unigenes (G), and 
Pearson’s correlations were calculated for each gene pair to construct correlation matrices 
(CC), which were subsequently ranked (R). A rank-statistic is used to evaluate the 
consistency of ranks observed for each gene pair, creating an interaction matrix of 2252 x 
2252 log likelihood ratio (LLR) values (see Methods). On the basis of a false discovery rate 









(B) Cumulative distribution of expression links in actual (orange circles) and randomly 
permuted networks (yellow circles) for absolute numbers of links (left axis, log scale) and 
FDR (right axis, linear scale), the latter being the ratio of random/actual links at a given 
LLR. Expression links were binned over LLR intervals of 0.5. Values for random data are 
the average of 50 permutations runs.  
 









 3.3.2 A Topological Analysis of the Gastrome Reveals a Hierarchical Scale-free 
Architecture with Embedded Modularity 
Previous reports analyzing the topologies of various biological networks in simpler 
model organisms such as bacteria and yeast have suggested a common ‘scale-free’ 
character. In a scale-free network, most of the connections are confined to a few 
major nodes (hubs), which link the other, lesser-connected nodes in the network. In 
contrast, in random or Gaussian networks, the connections are spread in a 
statistically homogenous manner across the nodes, such that most nodes have similar 
numbers of links (see Ref 16 and 20).  To determine the overall network architecture 
of the gastrome, we computed the probability P(k) of a gene having ‘k’ expression 
links, and found that P(k) was inversely related to ‘k’ following a power-law, a 
hallmark of scale-free networks (Fig. 3.3A). We confirmed this finding across a 
range of LLRs, indicating that an overall scale-free topology is a fairly robust feature 
of the gastrome, similar to that reported for other gene coexpression, protein 
interaction, and metabolic networks. However, despite this overt similarity in scale-
free character, we report here the possibility that there might exist formal differences 
between the different network types. Specifically, while γ, the slope of the power-law 
distribution, typically behaves as γ ∈ (2,3) for metabolic (20) or protein-interaction 
networks (21), γ appears to be consistently less than 2 for a number of gene 
coexpression networks (γ = 1.5-1.8, 1.5, and 1.1-1.8 for this study, Ref 22 and 23 
respectively). In general, a γ exponent in the range ∈ (1,2) will result in a network 
not possessing a characteristic mean and variance, along with being dominated by 
nodes with large degrees (24). An important consequence of this is since the overall 
number of nodes is finite; nodes of large degrees will be preferentially connected to 
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one another rather than to nodes of lesser degrees. To test this, we analyzed the 
cohort of highly connected genes within the gastrome, and found that genes with 
large numbers of expression links were indeed highly biased in connecting to other 
‘highly connected’ genes rather than genes with few connections (p<10-5), and that 
this phenomenon was not an automatic property of a generic scale-free system (Fig. 
3.4). This result suggests that gene coexpression networks, despite being scale-free, 
may nevertheless possess topological properties distinct from biological networks 
from other cellular levels. This peculiar network design may facilitate the cell’s 
ability to control the activity of multiple transcriptional programs in a coherent 
fashion. However, this is clearly speculative and more work is required to investigate 
the functional properties conferred by this particular systems organization. 
The cohort of highly connected genes was apparently skewed towards certain 
biological functions, in particular cellular proliferation (PCNA, CKS2, CRYAB, 
MAD2L1) and immune response (CD2, CD53, CCL19, THBS4). This finding made 
us consider if the gastrome, within its scale-free architecture, might also harbor 
additional sub-networks associated with distinct cellular functions and topologies. To 
formally address this possibility, we tested the gastrome for the presence of 
modularity. Modularity in a network refers to a set of nodes that are more internally 
connected compared to nodes from other parts of the network, which may represent 
functional sub-networks. We computed clustering coefficients ĈNo, a metric of global 
network modularity, for the gastrome at four different LLR cut-offs, and compared 
these coefficients to those found in either simulated pure scale-free or random 
gaussian networks, the latter possessing a non-scale free topology. At all LLR 
ranges, the clustering coefficient of the gastrome was substantially higher than either 
the pure scale-free or a gaussian network, indicating that the gastrome is indeed 
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highly modular (Table 3.4). Notably, the modularity of the gastrome, as reflected by 
ĈNo, became more evident when the LLR cut-off was increased – this is consistent 
with a hierarchical model of assembly where core modules are clearly discernible at 
a high LLR stringency, and relaxing this stringency subsequently ‘draws in’ 
expression links combining these modules, resulting in less cohesive structures (25). 
Previous work has shown that C(k) is essentially independent of ‘k’ for purely scale 
free or modular architectures, but for hierarchical networks C(k) reduces as ‘1/k’ 
(shows inverse proportionality; Ref. 16). To test the gastrome for such a hierarchical 
assembly, we computed the dependence of C(k) on ‘k’ at different LLRs. A typical 
case is shown in Figure 3.3B where the C(k) decreases with increasing ‘k’, thereby 
indicating the presence of hierarchy. Taken collectively, our topological analysis 
suggests that the gastrome is organized along a hierarchical scale-free architecture, 
with a deeply embedded sub-structure of distinct sub-networks and modules.  
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 Figure 3.3: Topological characteristics of the gastrome.  
 
(A) Power law distribution of the gastrome, with P(k) (Y-axis, log scale) being the 
probability of a gene having ‘k’ expression links (X-axis, log scale). P(k) = n(k)/nsig, where 
n(k) represents the number of  genes with k significant expression links, and nsig the total 
number of genes. Three different LLR cutoffs are depicted: ≥5 (pink squares), ≥6.5 (red 
triangles) and ≥8 (blue circles).  
 
(B) Evidence for a hierarchical assembly in the gastrome. The clustering coefficient ‘C(k)’ 
(Y-axis) is plotted on a log-log graph as a function of k (X-axis) at LLRcrit ≥5. In comparison 
to an equivalent pure scale free network (orange circles), a decrease in C(k) with increasing 
k is observed. Large circles represent smoothened values from the original data which is 








Figure 3.4: Connectivity Bias of ‘highly connected’ Genes  
 
For any scale free network, the top few nodes will account for a substantial number of 
connections. Here we compare how the most connected genes connect within themselves 
within the gastrome. At a given LLR cutoff, each gene is co-expressed with a set of other 
genes. The top 10% most connected genes at LLR 5 and 8 are used to check the fraction that 
exists within the coexpression neighborhoods of the top 10% genes themselves. This is 
plotted as a cumulative distribution graph with the X-axis representing the number of highly 
connected genes present in the coexpression neighborhood of the top 10 % genes (blue in 
Figures below). This is compared to an equivalent scale free network (red, the scale free 
network shown here is a typical simulation case). Compared to a pure scale free network, the 
coexpression network displays a bias in nodes with high degrees connecting to nodes with 
similarly high degrees. For example, at LLR5 within the gastrome 50% of the top connected 
genes have approximately 20 other highly connected genes in their coexpression 
neighborhoods, compared to 10 genes in the simulated pure-scale free network. The 
differences in the two cumulative distributions (< 10-5 for LLR8 and < 10-40 for LLR5) were 
assigned a p-value on the basis of a Kolmogrov-Smirnov test.  
 
                  
A) B)
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Table 3.4: Comparison of overall clustering coefficients at different LLRcrit cutoffs 
for the gastrome (ĈNo) and equivalent pure scale free (Ĉsf) and random (Gaussian) 
networks (Ĉrnd).  
 
(No), Number of nodes in the network with more than one coexpression partner, and (kavg), 
average number of coexpression partners of a vertex. Values in brackets for Ĉsf reflect the 




LLRcrit LLR ≥ 4 LLR ≥ 5 LLR ≥ 6.5 LLR ≥ 8 










ĈNo 0.166 0.174 0.217 0.271 
Scalefree  
m ~15 ~7 ~4 ~3 
Nsf 2200 1800 850 300 
Ĉsf 0.042 (0.006) 0.022 (0.003) 0.037 (0.004) 0.068 (0.014) 
Random  






3.3.3 A Modular Analysis of the Gastrome Reveals both Known and Novel 
Coexpression Subnetworks 
To identify these functional modules in the gastrome in a systematic and unbiased 
manner, we then implemented a novel bottom-up step-wise methodology referred to 
as ‘chain-linking’ (see Methods). For this analysis, we focused on the set of 
expression links above LLR8, since i) the modular structure of the gastrome is most 
apparent as this stringency and ii) these links have a low associated FDR (~1.6%), 
and are thus highly specific. In ‘chain-linking’, the expression links, comprising 925 
expression links across 588 unique genes, were combined into gene-gene maximal 
neighbor ‘chains’, and subsequently pooled into ‘communities’ with embedded tree 
like structures (Fig. 3.5) without restricting genes to be exclusively present in any 
single assembly. We then agglomerated those communities exhibiting high overlap 
into larger units. This latter property distinguishes the groupings defined by this 
approach from the conventional ‘expression clusters’ generated by hierarchical 
clustering algorithms. We constructed 298 gene-gene chains each of length ≥ 3 
genes, pooled them into 31 separate communities, and combined the communities 
exhibiting high overlap (>50%) into 13 distinct units (Fig. 3.6). Using random 
permutation assays, we also confirmed that each of these units was more internally 
than externally connected (p<0.0005 for all units), supporting their inherent 
modularity, and that the integrity of each unit was maintained even after variation of 
the LLR cut-off (See Appendix 3.6.3). We henceforth refer to these units as 
functional modules.   
We curated the modules and found that many of them could be assigned a functional 
or physiological role (Fig. 3.6; the complete gene lists are provided as a download. 
 94
See Appendix 3.6.4). Validating our basic methodology, some of these modules were 
previously described in the original reports as coexpression clusters; including those 
associated with a) Proliferation (PCNA, TOP2A, CDC2, CKS2, and MCM3), b) 
Interferon activity (ISGF3G, IFITM2, IFIT1, TRIM22, SP110) and c) Ribosomal 
function (RPS28, RPL35, RPL31, RPL19, RPS10). However, in addition to these 
known modules, other modules were novel and not obviously discernible from the 
original single data sets, demonstrating the utility of the meta-approach in improving 
and refining the inherent data sub-structure of such genome-wide expression data. 
For example, Module 1 is a novel module containing a highly significant number of 
nuclear and DNA-binding genes associated with the cell cycle (eg GSTP1, CKS1B, 
CKS2, PPP5C, p-values are <10-5, =0.0045, <10-5 for nuclear localization, DNA-
binding, and cell cycle activity respectively by the hypergeometric distribution), 
while Module 28 contains several genes related to epidermal development (LAMA3, 
EMP1, ANXA1, ITGB4, SERPINB5) (see Appendix 3.6.5 for a more in-depth 
analysis of these novel clusters). We believe that these novel modules are likely to be 
functionally meaningful, as their constituent member genes are both biologically 
coherent and robustly coexpressed and at high levels of specificity across all four 
independent microarray data sets. These examples demonstrate that the meta-
analytical approach can indeed uncover novel biological modules that can be 
subsequently targeted for further experimentation. 
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Figure 3.5: Schematic for organizing expression links into communities and 
subsequent modules  
 
Schematic of the ‘Chain-linking’ methodology for organizing expression links into 
communities and subsequent modules is shown. Each gene starts a chain that extends by 
connecting highest linked neighbors (unidirectional red arrows, each circle represents a 
distinct gene). The linking process continues until a gene is maximally linked with the 
preceding gene (bi-directional red arrows) whereupon the chain is terminated (Step I). 
Multiple chains ending in the same chain terminator pair are combined (Step II), and genes 
within the assembly whose links exceed an LLR threshold (shown as white circles, Step III) 
are combined to form a community.  
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Figure 3.6: Identification of modules from expression communities.  
 
A blue-white heat map depicts the similarity of each community to all other communities, 
with the depth of color reflecting the significance of overlap. The similarity is calculated on 
the basis of a hypergeometric test the details of which are given in the Methods section 3.2.4. 
Each community achieves the lowest probability, ie perfect overlap, with itself (dark blue 






3.3.4 Functional Modules have Highly Distinct Sub-topologies Consistent with 
their Different Biological Functions 
We then compared the individual connectivities of the different modules. In 
principle, the topologies of modules could belong to one of two contrasting 
scenarios. For example, a module might connect to other modules via several genes 
and expression links – in this case, parts of the former module would thus be 
integrated with and potentially regulatable by other modules. Alternatively, a module 
could be isolated, meaning that other modules would share very few to none of 
former module’s constituent genes and expression links – in this case the formers’ 
activity might be fairly autonomous and independent from other modules in the 
global network. To quantify the relative integration or isolation of the different 
modules, we defined a simple metric termed the ‘isolation index’, a ratio of external 
(inter-module) to internal (intra-module) links, and computed this index for all 
modules (Table 3.5). We observed a considerable range in the isolation indexes of 
the different modules - For example, some modules like the ribosomal module were 
highly isolated (isolation index of 0) while other modules in comparison were 
relatively integrated (Module 9, index 2.1). To ensure that these findings were not 
simply due to the spurious presence of a few key ‘outlier’ genes, we generated 
permuted data sets where 10%-20% of the genes within each module were randomly 
removed and repeated the analysis, comparing the module rankings obtained from 
the modified data to the original complete data set. Although there were slight 
variations in the rankings of adjacent modules (i.e. modules were highly similar 
indexes might sometimes switch places), the overall finding that certain modules 
appear to be integrated while others highly isolated was robust, supporting the idea 
that different functional modules can exhibit highly distinct topological structures 
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(Fig 3.7). There is biological consistency to this finding, as shown by Figure 3.8 
where the inter-relatedness of the modules is depicted. For example, modules 
associated with cellular proliferation were negatively linked and integrated with 
modules associated with cellular adhesion and extracellular matrix production, which 
may reflect the requirement of a rapidly proliferating tumor to dissociate the 
extracellular matrix potentially inhibiting its growth. In contrast, the externally 
isolated but highly internally connected nature of the ribosomal module may provide 
a mechanism for tightly balancing the relative transcript levels of each ribosomal 
subunit, thereby ensuring their protein products are produced in the appropriate 
stoichiometric balance for correct physical association and formation of a functional 
ribosomal complex. As we discuss later, such examples of “modular insularity” may 
emerge as a general design principle used by cells to I) ‘shield’ particular functional 
modules from excessive external regulation, and II) to ensure that genes within that 
specific module will act as a concerted unit.  
Intestinal metaplasia (IM) refers to the process where gastric epithelium begins to 
exhibit phenotypic traits reminiscent of intestinal epithelia such as expression of 
markers of intestinal epithelium.  Frequently found in association with gastric cancer, 
IM is regarded by some investigators as a potential pre-neoplastic cursor to gastric 
carcinogenesis (26). We observed that one module in the gastrome contained several 
co-expressed genes implicated in intestinal function and differentiation (ANXA13, 
CDX1, GUCY2C, VIL1), suggesting that it might be related to the IM process. 
Strikingly, this module exhibited an extremely high degree of topological isolation, 
being second only to the ribosomal module. The high insularity of this “intestinal 
module” raises the intriguing possibility that its specific topological properties may 
contribute to the frequent occurrence of IM in gastric cancer. To confirm that the 
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insularity of this module did not result from the inclusion of non-malignant IM 
tissues in the sample population, we repeated our analysis after deliberately 
removing all the non-cancerous IM samples and obtained similar results (Appendix 
3.6.6). As further evidence that this coexpression module is indeed present in tumor 
cells, we then examined the histological expression of VIL1, a hallmark gene of this 
module, and found that it was clearly observed within the malignant carcinoma cells 
of certain tumors (Fig. 3.9). Interestingly, there was little correlation between a 
tumor expressing this marker and belonging to the classical ‘intestinal’ histological 
subtype as defined by Lauren (Fig. 3.10, also see Appendix 3.6.7). Because the 
inherent autonomy of this intestinal module may prevent it from being strongly 
regulated by other modules or cellular pathways, its topological isolation may thus 
contribute to the process of IM by rendering the intestinal differentiation process, 
once initiated, to be essentially irreversible. Such autonomous modules may also play 
an important role in normal development and tissue differentiation, as evidenced by a 
separate module containing genes associated with normal gastric physiology (PGC, 
MSMB, ALDH3A1) also exhibiting a high isolation index. However, in cancer, these 
results raise the possibility that the inadvertent expression of such ‘self-sustaining’ 
modules may play a significant role in the pathologic expression of cancer-specific 
phenotypic traits. 
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Table 3.5: Isolation indexes of functional modules at LLR≥8 
 
The isolation index is given by (Links Out/Links In), the links between the constituents of a 
functional module vs. the links formed by the module with the rest of the modules. Shown 
are the numbers of unique genes in each functional module and genes that are shared 
between modules. Numbers in brackets depict the absolute numbers of links used to 









Number of genes 





1 Adhesion 119 25; 21% 0.27 (178/662) 
2 Immune Reaction 78 9; 11.5% 0.21 (70/328) 
3 Proliferation Chr:20 24 17; 70.8% 1.71 (116/68) 
4 Ribosomal 23 0; 0% 0 (0/96) 
5 Proliferation Chr:17q12q21 19 11; 57.9% 1.23 (81/66) 
6 Interferon Gamma 33 4; 12.1% 0.29 (34/116) 
7 Intestinal 20 2; 10% 0.07 (4/54) 
8 Digestive System 23 2; 8.7% 0.18 (9/50) 
9 Novel (13) 13 8; 61.5% 2.11 (59/28) 
10 Immuno-Gastric 12 5; 41.7% 0.88 (21/24) 
11 ER to Golgi transport 12 4; 33% 1.23 (32/26) 
12 Novel (28) 10 1; 10% 0.18 (5/28) 
13 Novel (1) 10 3; 30% 1.72 (31/18) 
  344 unique    
 
 101
Figure 3.7: Stability in the isolation indexes of the functional modules  
 
(A and B) From each functional module, 10% (A) or 20% (B) of the genes were removed 
and the isolation index was re-computed for 100 such random removals. The distribution is 
plotted in form of a box plot with “+” signs being the cases where the isolation index 
exceeds the inter quartile range. The modules retain their overall relative position with one 
another, with the digestive functional module shows a isolation index lesser than of the 
intestinal module only 12/1000 times (0.012).  The Y-axis shows the log (isolation index) 
and X-axis shows the Functional units. When 20% genes are removed, the isolation index in 








 Figure 3.8: Higher order relationships between communities and modules.  
 
Each circle represents a community of various genes (list provided in supplementary 
section), and different colors represent distinct modules. Similarities between any two 
communities were computed as in B), and lines connecting various communities and 
modules correspond to cases where the significance of overlap ≤ 10-5. Thicker lines represent 
overlaps of higher significance (lower p-values). (D) Villin1 expression in gastric 
adenocarcinomas. Two tumors are shown (top and bottom panels) both exhibiting glandular 
architecture corresponding to the Lauren’s intestinal subtype. (Left panels): Haematoxylin 
and Eosin staining, (Right panels): Villin1 immunostaining. Intense villin1 expression is 
clearly noted in the tumor cells of the top tumor but not in the bottom tumor. 
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 Figure 3.9: Villin1 expression in gastric adenocarcinomas.  
 
Two tumors are shown (top and bottom panels) both exhibiting glandular architecture 
corresponding to the Lauren’s intestinal subtype. (Left panels): Haematoxylin and Eosin 
staining, (Right panels): Villin1 immunostaining. Intense villin1 expression is clearly noted 
in the tumor cells of the top tumor but not in the bottom tumor. 
 
Haematoxylin and Eosin staining Villin1 expression 
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 Figure 3.10: Presence of intestinal and non-intestinal groups across multiple datasets 
and their correlation with Lauren’s intestinal type histological classification  
 
Heat-maps for all four datasets are shown using the intestinal functional group signature. A 
group of samples in each dataset are seen to have a very strong Intestinal signature (Blue 
bar) and there is no consistent relation between the presence of intestinal markers (shown as 
blue bar) and the intestinal type histopatological classification (shown as orange bar). (A) 
Dataset AU comprises of 65 samples (22 Intestinal, 35 Diffused, 7 Mixed and 1 
Adenosquamous). (B) Dataset SG comprises of 55 malignant samples (40 Intestinal, 13 
Diffused and 2 Mixed). (C) Dataset HK comprises of 90 malignant samples (68 Intestinal, 13 
diffused, 8 mixed and 1 indeterminate). (D) Dataset JP comprises of 22 malignant samples 
(17 Intestinal and 5 Diffused) (I = Intestinal (light orange), D = Diffused, M = mixed, AS = 
Adenosquamous, IND = Indeterminate). Datasets AU, SG, HK, JP gave highly insignificant 











 3.3.5 A Gene Neighborhood Analysis of the Gastrome Reveals Novel 
Interactions Between Phospholipase PLA2G2A and the EphB2 Receptor 
To gain insights into the component pathways affected in gastric cancer, we then 
performed an analysis of ‘gene neighborhoods’, referring to the set of closest 
coexpression partners associated with any particular gene. As an example of such 
‘neighborhood analysis’, Junction Plakoglobin/γ-Catenin (JUP), which resides on 
Chromosome 17q12q21, possesses a coexpression neighborhood of several other 
17q12q21genes within the gastrome (TOP2A, GRB7, TRAP100, PSMB3), suggesting 
that a 17q12q21 coexpression amplicon is likely to be present in a certain proportion 
of tumors from all four patient populations.  
In this work, we focused on Phospholipase II Group 2A (PLA2G2A), a 
secreted phospholipase whose expression was recently found to be of prognostic 
significance in gastric cancer (15), but for which little is known concerning its actual 
molecular function in gastric tumors. Using neighborhood analysis, we found that the 
coexpression neighborhood of PLA2G2A in the gastrome contained the cell surface 
receptor EphB2, and β-Catenin, a central member of the Wnt signaling pathway 
(other PLA2G2A neighbors are PPP2R3A, H2AFX, MUT, ARSD, LMO4, PDIP, 
HPGD, CPA2). Next, to validate the coexpression association between PLA2G2A 
and EphB2, we analyzed a series of gastric tumor tissue microarrays and found that 
the histological expression of PLA2G2A mRNA and EphB2 protein was indeed 
significantly correlated (p= 0.017, χ2-test, See Fig. 3.11A and Table 3.6). It was also 
noted that the poor correlation could be due a small percentage of cells that express 
EphB2 also express PLA2G2A. We also asked if the association between PLA2G2A 
and EphB2 could have been discerned by conventional single-data set analysis rather 
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than the meta-analytical approach by re-examining the former and found that in the 
individual data sets EphB2 expression was only modestly correlated to PLA2G2A 
(Pearson’s correlation values of 0.4521, 0.3746, 0.4908 and 0.2129 in datasets AU, 
HK, JP and SG respectively). As a consequence, approximately 57k, 150k, 68k, 621k 
pairwise gene interactions (within the 2252 common genes) in each of the data sets 
exhibit higher correlation values than that observed between PLA2G2A and EphB2. 
The lack of a strong correlation between PLA2G2A and EphB2 in any of the data sets 
makes it unlikely that it would have been identified as a likely biological interaction 
in any of the single data sets when analyzed in isolation. In the absence of knowing 
that this moderate correlation is conserved across multiple data sets, it is quite 
unlikely that such an interaction would have been identified as significant in any of 
the original analyses. Indeed, it was stated in one of the original reports (15) that 
“…the pattern of variation in PLA2G2A expression among (the) gastric cancer 
samples was not closely related to that of any other genes”.  
EphB2 is a known target gene of the Wnt/β-catenin signaling pathway (27). The 
significant coexpression interaction between EphB2 and PLA2G2A expression thus 
made us consider that the Wnt signaling may also regulate PLA2G2A in human 
gastric cancer (notably, β-catenin is also present in the gene neighborhood of 
PLA2G2A). To explore the relationship between Wnt signaling and PLA2G2A, we 
assayed a series of gastric cancer cell lines for both PLA2G2A expression and the 
presence of cytoplasmically accumulated / nuclear-localized β-catenin, indicating 
high Wnt signaling activity. Two out of six cell lines (KATOIII and AGS) exhibited 
nuclear staining of β-catenin, and remarkably these were also the only two cell lines 
to express PLA2G2A (Fig. 3.11B and Fig. 3.11C). However, it was also observed that 
all KATO-III cells do not have activated β-catenin. We could not confirm whether 
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some KATO-III cells have low β-catenin below the detection limit or because of ‘no’ 
β-catenin actually being present in cytoplasm. Nonetheless, the simultaneous 
presence of β-catenin and PLA2G2A in two different cases further supports an 
association between Wnt signaling and the expression of PLA2G2A.  
Finally, to ask if manipulation of the Wnt pathway could influence PLA2G2A 
expression, we then re-analyzed two public gene expression data sets – the first from 
APC -/- mice where Wnt signaling is constitutively activated (28), and the second 
from a colon cell line where Wnt signaling is inhibited by a dominant-negative TCF4 
transgene (29) (dnTCF4). We found that in the former, PLA2G2A was 
transcriptionally upregulated in APC(-/-) intestinal epithelium compared to wild-type 
tissue (>7 fold), while in the latter PLA2G2A was modestly suppressed (1.5-2 fold) in 
cells expressing dnTCF4 compared to cells where the transgene was not induced 
(Appendix 3.6.8). Taken collectively, these results are thus consistent with a model 
for PLA2G2A being a target of the Wnt signaling pathway. More work is required to 




 Table 3.6 χ2 test showing significance of correlation between EphrinB2 protein 
expression (EphB2) and Phospholipase A2 Group IIA (PLA2G2A) in-situ expression.  
 
The data here is obtained from a 343 gastric tumor tissue microarray. The p-value of the 





Negative - Weak Moderate - Strong 
 
Negative - Weak 185 100 285 
EphB2 
Moderate - Strong 28 30 58 




Figure 3.11: Expression interactions between EphB2, PLA2G2A, and β-catenin.  
 
(A) A tissue microarray showing two gastric adenocarcinomas  (top and bottom rows) 
examined by H&E staining (first column), EphB2 expression (second column, deep brown 
membranous staining), and PLA2G2A expression (in-situ hybridization, brown cytoplasmic 
granular staining). AS: Antisense riboprobe and S: sense riboprobe. The top tumor co-
expresses EphB2 and PLA2G2A, while the bottom tumor is negative for both EphB2 and 
PLA2G2A expression. A control hybridization for β-actin confirms the RNA integrity of the 






(B) Immunohistochemical staining of β-catenin in gastric cancer cell lines. Aberrant nuclear 
expression of β-catenin is observed in cell lines KATOIII (red arrows) and AGS (right 
panels), but not in SNU16 (left panel). Similar non-nuclear staining was observed for cell 
lines SNU1, SNU5, and NCIN87 (data not shown).  
 
(C) Expression levels of PLA2G2A in gastric cancer cell lines. The graph depicts the 
expression level of PLA2G2A across the six cell lines (three replicates each) as determined 
by Affymetrix U133A arrays. Only KATOIII and AGS are seen to express PLA2G2A. Note 
that the level of PLA2G2A expression in KATOIII and AGS correlates with the extent of 






Gastric adenocarcinoma is a leading cause of global cancer mortality, surpassed only 
by lung (10). The improvement of gastric cancer diagnosis and treatment will 
undoubtedly require developing molecular classification schemes that are both robust 
and clinically meaningful, and several reports have recently described gene 
expression profiles of gastric tumors for this purpose (11-14). However, as these 
studies were performed using different technology platforms, clinical protocols, and 
patient populations, a critical challenge is to validate the robustness and generality of 
such initial discoveries in a larger series of patients and tissue samples. As this 
scenario pertains to essentially all cancers for which gene expression analysis has 
been reported, it is likely that some of the general approaches and methodologies we 
have developed in this report will be applicable to many other cancer types as well.  
In order to identify gene coexpression relationships that were robustly conserved 
across the multiple data sets, we employed a rank-based statistical methodology 
conceptually similar to a previous study identifying evolutionarily conserved patterns 
of gene coexpression (22). This approach is distinct from a number of previously 
reported meta-analytical reports of cancer transcriptomes, as it does not rely on 
performing inter-group comparisons to define differential expression signatures from 
multiple datasets (7), and is focused on a single cancer type as opposed to all cancers 
(9). In our study, the success of the meta-analytical approach in identifying hitherto 
undetected subtle but significant gene coexpression relationships is likely due to both 
having larger sample sizes for additional statistical power and also to the use of 
multiple independent datasets to identify conserved associations. The former 
(increased sample size) increases the sensitivity of detection, while the latter 
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(conserved behavior) increases specificity. For example, the expression of EphB2 is 
only moderately correlated to PLA2G2A in the individual data sets (each containing 
different numbers of samples), but the preservation of this correlation across the four 
sets allows it to be identified above other interactions that display ‘strong’ 
interactions in one data set but not in others. The network-driven approach also 
possesses a number of advantages compared to the conventional hierarchical 
clustering algorithms commonly used in such studies. In hierarchical clustering, the 
distance or similarity-based metrics used to cluster group of genes (and samples) are 
usually based upon pre-processed gene sets selected using arbitrary fold change or 
variance cutoffs. Such an approach offers no correction for potential false positive 
relationships.  In contrast, the network analyses used in this study combines data 
from multiple independent studies to perform a rigorous assessment of the false 
discovery rate (FDR). Furthermore, as genes can have multiple cellular functions, 
another advantage of the network approach is the ability to assign a gene to multiple 
clusters, unlike hierarchical clustering where genes are assigned to single individual 
clusters.  
We note that this study possesses a number of limitations. First, by focusing on 
conserved gene behavior, this study necessarily identifies common aspects of gastric 
cancer that are preserved across the different patient populations and array studies. 
As such, we are unable to infer if there are population-specific differences in the 
molecular features of gastric cancer between the different countries. Second, this 
study is limited to the number of genes commonly found across the data sets (2252), 
and consequently does not provide information regarding other potentially important 
genes. Nevertheless, it should be possible to utilize the consensus framework defined 
in this study as a core molecular scaffold to which additional genes can be added as 
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more information becomes available. Third, the gene expression data used in this 
analysis provides only a static snapshot of the collective gene expression interactions 
occurring within a complex tissue sample, and is thus likely to under-represent both 
the dynamic nature of these interactions, and whether they arise in either single or 
multiple cell types within the tumor. Fourth, the network presented in our report is 
undoubtedly simplified as it employs binary relationships between genes and does 
not consider the ‘strength’ of the relation. Nevertheless, it is apparent that even a 
‘simplified’ version of the real network can be useful in identifying novel biological 
associations for hypothesis generation and subsequent experimental testing, which 
provides a strong biological motivation for this form of research.  
We analyzed the coexpression relationships within the gastrome at the levels of 
network topology and functional modules. Such higher-level analyses have proved 
useful in elucidating various systems-level properties of biological networks, such as 
robustness to perturbations (30-31), module evolution (7), and oscillatory behavior 
(32). It is not unreasonable that a similar systems-level description of cancer 
transcriptomes might also provide insights into the complex biological properties of 
tumors, including independence from local growth control, derangement of cellular 
architecture, and the adoption of novel tissue phenotypes (e.g. metaplasia). We found 
that the global architecture of the gastrome was consistent with a hierarchical scale 
free topology containing several deeply embedded modules, and that different 
modules appeared to possess distinct sub-topologies - certain modules were 
relatively integrated with others, while other modules were relatively isolated. 
Although we cannot definitely rule out that some of our topological inferences may 
be a consequence of our specific methodology, we believe that they are unlikely to 
be complete artifacts, for the following reasons: I) we focused on gene-gene 
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relationships that are strongly conserved multiple independent data sets; such 
relationships are unlikely to be technical errors, II) the sub-networks constructed in 
this study display strong biological coherence, as reflected by their individual 
constituent genes exhibiting similar cellular functions (eg intestinal and gastric 
differentiation, etc), and III) using different network construction methods, other 
groups have also reported similar topological findings, albeit in simpler organisms 
such as bacteria and yeast (22,23). However to our knowledge, this is the first report 
demonstrating the presence of topological differences between different functional 
modules. We propose that such differential ‘insularity’ may reflect a general design 
principle utilized by cells to delegate specific functional roles to groups of genes, and 
to ensure their proper functioning by inhibiting or facilitating inter-module cross-talk 
(33). Regarding intestinal metaplasia, we suggest that once the intestinal module is 
initiated, the highly internally connected nature of the module may cause the 
remainder of the module members to be similarly activated to manifest the complete 
intestinal differentiation phenotype. In addition, the ‘insularity’ of this module may 
prevent this differentiation process from being regulated by other modules. The 
potential role of such systems-level features in contributing to the cancer phenotype 
needs to be further investigated.  
We also studied the gastrome at the level of individual genes and pathways. 
Specifically, we analyzed the gene PLA2G2A, a secreted phospholipase identified in 
a previous study as a molecular prognostic marker for gastric cancer (15). Although 
previous work has implicated PLA2G2A activity in a wide variety of cellular 
functions, including prostaglandin biosynthesis, inflammatory responses and 
antibacterial activity (34) the exact nature of PLA2G2A’s role in gastric cancer 
remains unclear. To identify potential cellular pathways affected by PLA2G2A in 
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gastric cancer, we explored the coexpression neighborhood of PLA2G2A in the 
gastrome and found that it contained both β-catenin, a major component of the Wnt 
signaling pathway, and the EphB2 receptor, a target of Wnt/β-catenin signaling. 
These results, coupled with our additional supporting data that the Wnt pathway may 
regulate PLA2G2A expression, raises the intriguing hypothesis that one of 
PLA2G2A’s roles in gastric cancer may be to modulate the activity of the Wnt 
pathway. As our tumor expression profiles only provide a static snapshot of these 
interactions, it is not possible to definitely establish from our data if PLA2G2A might 
function as a positive or negative regulator of Wnt signaling. We note however, that 
i) PLA2G2A was previously identified as a genetic modulator of colon cancer in the 
APCmin mouse model (35), and that ii) that high levels of PLA2 have been shown to 
suppress colon cancer formation (36). This potential connection between PLA2G2A 
and the Wnt pathway definitely deserves further study.  
In conclusion, we have described in this chapter a consensus molecular framework 
for gastric cancer, and shown how an analysis of this framework can deliver novel 
topological and functional insights. More broadly, our results demonstrate how meta-
analytical approaches, by capitalizing on greater sample numbers and focusing on 
conserved gene behavior, can aid in identifying subtle but potentially important 
biological relationships relevant to tumor biology. With the rapidly increasing 
availability of such data sets in the public domain, it is likely that such meta-
analytical approaches will play a valuable role in elucidating both general and tissue-
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3.6 Appendix 
3.6.1 Summary of Histopathological and Clinical Information of the Tumors in 
each Dataset.  
 
Table 3.7 Summary of histopathological and clinical information of the tumors in 
each dataset. 
 
In addition to these samples, dataset AU comprised of 59 non-malignant samples 
(comprising of 10 normal, 26 chronic gastritis, 22 intestinal metaplasia and 1 Squamous), 
dataset JP comprised of 8 normals and dataset SG comprised of 3 normals.  
 
 
  AU HK JP SG 
 Cases 65 90 22 55 
 Male 45 51 16 39 
 Female 20 39 6 16 
 










TNM stage IA 3 1 0 2 
 IB 9 12 6 6 
 II 15 19 3 15 
 IIIA 22 25 6 11 
 IIIB 13 12 5 8 
 IV 3 21 2 13 
Lauren Intestinal 22 68 17 40 
 Diffuse 35 13 5 13 
 Mixed 7 8 0 2 
 Others 1 1 0 0 
Differentiation  Well 4 3 11 1 
 Moderate 13 41 6 30 
 Poor 44 46 5 20 
 unknown 4 0 0 4 
Subsite cardia 10 28 5 9 
 fundus 0 0 0 0 
 corpus 35 20 2 25 
 antrum 14 41 11 15 





3.6.2 Definition of Coexpression 
It is important to note that although the correlation (A → B) = correlation (B → A), 
the ranks of gene A with respect to gene B will not be the same as ranks of gene B 
with respect to. gene A. Hence, in general it can be said that, LLR(A → B) ≠ LLR(B 
→ A).  
We define LLR(A ↔ B) = Max { LLR(A → B) , LLR(B → A) }. Two genes A and 
B are called co-expressed iff LLR (A ↔ B) ≥ LLRcrit (LLRcrit is based on the desired 
FDR). All analyses reported use this definition of coexpression.  
For example, TOP2A and PCNA are correlated in 4 datasets (AU, HK, JP, SG) at 
0.73, 0.62, 0.75 and 0.62 (Pearson’s Correlation). Ranks of PCNA with respect to 
TOP2A are [2240, 2193, 2239, 2241], and the ranks of TOP2A with respect to 
PCNA are [2224, 2230, 2242, 2244]. The corresponding LLR scores are 10.44 and 
9.84.  
 
∴ LLR (TOP2A ↔ PCNA) = Max { LLR (TOP2A → PCNA) , LLR (PCNA → 
TOP2A) }.  
Hence, LLR(TOP2A ↔ PCNA)= 10.44. TOP2A and PCNA will be called co-
expressed for LLRcrit ≤ 10.44. 
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3.6.3 Robustness of Coexpression Communities 
Expression communities formed at any given LLRcrit are also preserved at lower or 
higher LLR cutoffs but with proportionately larger or smaller sizes respectively. For 
example, we have confirmed that all communities that are formed with LLRcrit ≥ 8.5 




Genes with at 
least 1 partner 
Chains with 






7.5 781 399 1368 2.3 47 
8 588 298 925 1.6 31 
8.5 467 221 681 0.8 23 
 
 
Figure 3.12: Robustness of coexpression communities 
 
Choosing a higher LLRcrit obviously reduces the number of genes and hence the communities 
that are formed are correspondingly of smaller size. Also, as the cutoff is relaxed (or made 
stringent) there are more genes available to be added into the coexpression network thereby 



















3.6.4 Members of Coexpression Communities  
The Gene groups and their descriptions are provided as a zip file 
(31Communities.zip) downloadable from http://www.omniarray.com/GCGC with 31 
communities depicted in Figure 3.8 of the Main Text and reproduced below. For 
example, the intestinal functional module formed by the two communities marked 6 
and 20 are present in the file as 6.txt (format shown here) and 20.txt containing the 
genes and descriptions.  
6.txt 
DPEP1  dipeptidase 1 (renal)  
EPHB2  EphB2  
CDX1 caudal type homeo box transcription factor 1  
GUCY2C  guanylate cyclase 2C (heat stable enterotoxin receptor)  
ANXA13  annexin A13  
BENE  BENE protein  
MUC2  mucin 2, intestinal/tracheal  
VIL1  villin 1  
LGALS4  lectin, galactoside-binding, soluble, 4 (galectin 4) 
TFF3  trefoil factor 3 (intestinal)  
CDH17  cadherin 17, LI cadherin (liver-intestine)  
 
20.txt 
DPEP1  dipeptidase 1 (renal)  
PPP2R3A protein phosphatase 2 (formerly 2A), regulatory subunit B'', alpha  
CDC25B  cell division cycle 25B  
CDX1  caudal type homeo box transcription factor 1  
GUCY2C  guanylate cyclase 2C (heat stable enterotoxin receptor)  
ANXA13  annexin A13  
BENE  BENE protein  
TG737  Probe hTg737 (polycystic kidney disease, autosomal recessive)  
TM4SF8  transmembrane 4 superfamily member 8  
FKBP1A  FK506 binding protein 1A, 12kDa  
DDC  dopa decarboxylase (aromatic L-amino acid decarboxylase)  
CRA  cisplatin resistance associated  
GLUL  glutamate-ammonia ligase (glutamine synthase)  
HIP1  huntingtin interacting protein 1  
VIL1  villin 1  
TFF3  trefoil factor 3 (intestinal)  




3.6.5 Possible Functions of Novel Coexpression Modules 
Possible functional role of three novel expression modules were identified in the 
gastrome is described below.  
(A) Module 13: Novel (1): 10 genes; Hypothesized Function: Cell Cycle 
The constituent members of this functional module at log likelihood ratio (LLR) 8 
are as follows. 
NME1 non-metastatic cells 1, protein (NM23A) expressed in 
H2AFX H2A histone family, member X 
U5-116KD U5 snRNP-specific protein, 116 kD 
SKB1 SKB1 homolog (S. pombe) 
FHL1 four and a half LIM domains 1 
PPP5C protein phosphatase 5, catalytic subunit 
SNRPG small nuclear ribonucleoprotein polypeptide G 
NASP nuclear autoantigenic sperm protein (histone-binding) 
RAD54L RAD54-like (S. cerevisiae) 
TKT transketolase (Wernicke-Korsakoff syndrome) 
 
(Italicized genes are negatively correlated to the rest of the group. To call a gene as negatively 
regulated we averaged the ranks of the gene with respect to the rest of the 2251 common genes across 
the four datasets. Average ranks below 2252/2 and above 2252/2 are called negatively and positively 
correlated respectively) 
 
Chromatin-associated (H2AFX, RAD54L, NASP) and small nuclear riboprotein 
(U5-116KD, SNRPG) genes are present, pointing to transcriptional control and/or 
mRNA processing. DNA binding activity is also exhibited by most of these genes 
(see below). Subsequently, we relaxed the LLR to 7, to increase sensitivity for ease 
of assessment of the function based on other genes that are co-expressed with these 
genes.  These are given below. 
BYSL bystin-like 
RFC3 replication factor C (activator 1) 3, 38kDa 
NME1 non-metastatic cells 1, protein (NM23A) expressed in 
H2AFZ H2A histone family, member Z 
H2AFX H2A histone family, member X 
U5-116KD U5 snRNP-specific protein, 116 kD 
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ALG3 asparagine-linked glycosylation 3 homolog (yeast, alpha-1,3-mannosyltransferase) 
RAB9P40 Rab9 effector p40 
MYC v-myc myelocytomatosis viral oncogene homolog (avian) 
LAMP2 lysosomal-associated membrane protein 2 
GSPT1 G1 to S phase transition 1 
POLD2 polymerase (DNA directed), delta 2, regulatory subunit 50kDa 
PPAT phosphoribosyl pyrophosphate amidotransferase 
EBNA1BP2 EBNA1 binding protein 2 
OK/SW-cl.56 beta 5-tubulin 
DTYMK deoxythymidylate kinase (thymidylate kinase) 
SKB1 SKB1 homolog (S. pombe) 
CKS1B CDC28 protein kinase regulatory subunit 1B 
FHL1 four and a half LIM domains 1 
PPP5C protein phosphatase 5, catalytic subunit 
POLR2H polymerase (RNA) II (DNA directed) polypeptide H 
ENO1 enolase 1, (alpha) 
MTHFD1 methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthetase 
SNRPG small nuclear ribonucleoprotein polypeptide G 
PAICS phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase 
NASP nuclear autoantigenic sperm protein (histone-binding) 
EED embryonic ectoderm development 
RAD54L RAD54-like (S. cerevisiae) 
CKS2 CDC28 protein kinase regulatory subunit 2 
KIF11 kinesin family member 11 
TKT transketolase (Wernicke-Korsakoff syndrome) 
 
A Gene Ontology analysis showed 23/31 genes had cellular location information 
available, with 14/23 having the ability to be localized to nucleus (p<10-5 by the 
hypergeometric distribution). The cell-cycle transcription factor MYC and replication 
factor 3 (RFC3) are present, and many of these genes are linked to different aspects 
of the cell cycle (p<10-5) and have DNA-binding activities (p=0.0045). For example, 
GSTP1: G1/S phase,  
CKS1B and CKS2: Cell cycle,  
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PPP5C: Phosphatase involved in cell cycle,  
POLD2: DNA polymerase and replication,  
ENO1: c-myc promotor binding activity (MYC promoter binding protein 1),  
KIF11: Kinesin involved in mitotic spindle assembly. 
 
 
(B) Module 12: Novel (28):  Hypothesized function: Epidermal Development 
The constituent members of this functional module at log likelihood ratio (LLR) 8 
are as follows. 
 
XRCC4 X-ray repair complementing defective repair in Chinese hamster cells 4 
LAD1 ladinin 1 
KRT7 keratin 7 
ANXA1 annexin A1 
EMP1 epithelial membrane protein 1 
SMARCD3 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 
SERPINB5 serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 5 
TRIM29 tripartite motif-containing 29 
LAMA3 laminin, alpha 3 
ITGB4 integrin, beta 4 
 
 
Genes such as LAMA3 (linkage of epidermal cells to basement membrane), KRT7 
(Type II cytokeratin specifically expressed in the simple epithelial lining of cavities 
of internal organs), ITGB4 (mediate Cell-Cell and Cell-Matrix adhesion; act as a 
receptor for laminins) along with presence of EMP1 and AnnexinA1 (squamous 
epithelial cell differentiation markers) are suggestive of epidermal development. On 
looking at co-expressed genes in this module after relaxing the LLR cutoff, TGFA 
(Epidermal Differentiation), EpherinA1 (Cell Migration) and BAD and CIRBP 




DGKD diacylglycerol kinase, delta 130kDa 
XRCC4 X-ray repair complementing defective repair in Chinese hamster cells 4 
FAT FAT tumor suppressor homolog 1 (Drosophila) 
TGFA transforming growth factor, alpha 
LAD1 ladinin 1 
BENE BENE protein 
ITGA6 integrin, alpha 6 
KRT7 keratin 7 
PRKAR1A protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) 
ANXA1 annexin A1 
EMP1 epithelial membrane protein 1 
SNTA1 syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component)
TPMT thiopurine S-methyltransferase 
ITPK1 inositol 1,3,4-triphosphate 5/6 kinase 
MSLN mesothelin 
GNAZ guanine nucleotide binding protein (G protein), alpha z polypeptide 
CIRBP cold inducible RNA binding protein 
GLUL glutamate-ammonia ligase (glutamine synthase) 
SMARCD3 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 
C12orf8 chromosome 12 open reading frame 8 
SERPINB5 serine (or cysteine) proteinase inhibitor, clade B (ovalbumin), member 5 
CD58 CD58 antigen, (lymphocyte function-associated antigen 3) 
PMM1 phosphomannomutase 1 
BAD BCL2-antagonist of cell death 
TRIM29 tripartite motif-containing 29 
LAMA3 laminin, alpha 3 
ITGB4 integrin, beta 4 




(C) Module 9:  Novel (13): 13 genes; Hypothesized function: ECM linked survival 
pathway   
The constituent members of this functional module at log likelihood ratio (LLR) 8 
are as follows. 
GPC3 glypican 3 
CIB1 calcium and integrin binding 1 (calmyrin) 
PEA15 phosphoprotein enriched in astrocytes 15 
MYH10 myosin, heavy polypeptide 10, non-muscle 
ARHGDIB Rho GDP dissociation inhibitor (GDI) beta 
MST1R macrophage stimulating 1 receptor (c-met-related tyrosine kinase) 
PRCP prolylcarboxypeptidase (angiotensinase C) 
KCNK1 potassium channel, subfamily K, member 1 
SALL2 sal-like 2 (Drosophila) 
MAP17 membrane-associated protein 17 
A2M alpha-2-macroglobulin 
GNAI2 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 
LAMA3 laminin, alpha 3 
 
 
LAMA3, CIB1, MST1R are negatively correlated to other genes in this module (eg 
ARHGDIB, a negative regulator of cell adhesion) and have a functional role in cell 
adhesion and motility. Genes such as SALL2 (regulator of cell growth and survival1), 
GPC3 (Inhibits cell proliferation and regulates cell survival with a suggested role as a 
tumor suppressor2) and PEA15 (Anti-apoptotic function, protects cells from stress-
induced apoptosis3) are observed, showing interplay between genes linked to survival 
and apoptosis.  
The list of genes present in this module at LLR 7 are as follows: 
                                                          
1 p150(Sal2) is a p53-independent regulator of p21, Mol Cell Biol. 2004, 24(9):3885-93 
2 Processing by proprotein convertases is required for glypican-3 modulation of cell survival, Wnt 
signaling, and gastrulation movements, The Journal of Cell Biology, Volume 163, Number 3, 625-635 
3 Multiple Members of the MAP Kinase Family Are Necessary for PED/PEA-15 Anti-apoptotic 




GPC3 glypican 3 
CIB1 calcium and integrin binding 1 (calmyrin) 
ARHGDIA Rho GDP dissociation inhibitor (GDI) alpha 
PEA15 phosphoprotein enriched in astrocytes 15 
MYH10 myosin, heavy polypeptide 10, non-muscle 
ARHGDIB Rho GDP dissociation inhibitor (GDI) beta 
MST1R macrophage stimulating 1 receptor (c-met-related tyrosine kinase) 
FXYD3 FXYD domain containing ion transport regulator 3 
PRCP prolylcarboxypeptidase (angiotensinase C) 
TCF4 transcription factor 4 
KCNK1 potassium channel, subfamily K, member 1 
TPMT thiopurine S-methyltransferase 
ITPK1 inositol 1,3,4-triphosphate 5/6 kinase 
DAF decay accelerating factor for complement (CD55, Cromer blood group system),
SALL2 sal-like 2 (Drosophila) 
CRA cisplatin resistance associated 
MAP17 membrane-associated protein 17 
ADPRTL1 ADP-ribosyltransferase (NAD+; poly (ADP-ribose) polymerase)-like 1 
SCNN1A sodium channel, nonvoltage-gated 1 alpha 
A2M alpha-2-macroglobulin 
AIF1 allograft inflammatory factor 1 
GNAI2 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 
LGALS9 lectin, galactoside-binding, soluble, 9 (galectin 9) 
LAMA3 laminin, alpha 3 




3.6.6 Robustness of Intestinal Differentiation Module to Non-Malignant 
Samples 
We asked if the presence of non-malignant intestinal metaplasia samples in the 
dataset could influence the identification of the intestinal differentiation module. 
Each dataset had a different mix of malignant and non-malignant samples. We 
generated the coexpression network after removing all non-malignant samples 
(normals, chronic gastritis and intestinal metaplasia) from each dataset. 61% percent 
of coexpression links are conserved between the two networks at LLRcrit 8. To 
specifically check for the conservation of the functional units linked to intestinal 
differentiation markers by comparing this group to its counterpart in the complete 
gastrome network generated under the same LLRcrit cutoff. 
Intestinal differentiation markers: 
a) Complete dataset 
DPEP1, EPHB2, CDX1, GUCY2C, ANXA13, BENE, LGALS4, GLUL, VIL1, 
CDH17, MUC2, PPP2R3A, CDC25B, TG737, TM4SF8, FKBP1A, DDC, CRA, 
HIP1, TFF3. 
b) Malignant samples only 
DPEP1, EPHB2, CDX1, GUCY2C, ANXA13, BENE, LGALS4, GLUL, VIL1, 
CDH17, LGALS3, BMP4, TLX1, TM4SF4, CYP2J2, PKP2. 
The genes different between the complete dataset and the “malignant sample only” 
dataset are shown in italics. Most of the genes are preserved, suggesting the intestinal 
differentiation module is robust. 
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3.6.7 Repeated Observation of Intestinal-like and Non-intestinal Like Subclasses 
of Gastric Cancers in Multiple Datasets 
 
Two histological variants of gastric cancer (Lauren’s Classification scheme; 
Intestinal and Diffuse) are routinely used to classify gastric cancer. The current 
model for intestinal type gastric cancer involves gastritis proceeding to chronic 
atrophic gastritis, followed by intestinal metaplasia, dysplasia, eventually leading to 
carcinomaΛ. In the Main Text, we describe a functional module with several 
intestinal differentiation markers identified by the meta-approach. The presence of 
this robust expression signature, along with the popularity of Lauren’s classification, 
made us explore the relationship between the molecular and histopathological 
classifications. The samples in each dataset were clustered on the basis of these 
genes (Fig 3.10). In each dataset, we observed 2 groups, one with high expression of 
these genes along with another group with absence of these genes. No consistent 
association was found between the presence of intestinal signature and Lauren’s 
histopathological classification scheme. Datasets AU, SG, HK, JP gave highly 
insignificant χ2 p-values 0.43, 0.17, 0.69, 0.68 respectively. We then checked if the 
lack of intestinal module expression in “Lauren’s Intestinal” tumors might be due to 
contaminating normal tissue. First, we located a functional module that could 
separate malignant from non-malignant samples (digestive system genes), and 
generated clustergrams with all samples (both malignant and non-malignant) and the 
two gene groups (intestinal markers and gastric system genes) were generated and 
shown in Figure 3.13. The absence of high expression of intestinal differentiation 
markers and expression of gastric enzymes can be used as an indicator of 
                                                          
Λ Yuasa, Y. Control of gut differentiation and intestinal-type gastric carcinogenesis, Nat. Rev. Cancer 3, 592-600 
(2003) 
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contaminating normal tissue. The majority of the samples with absence of intestinal 
genes did not show any high gene expression of digestive system genes. We thus 
conclude that presence of contamination is not the cause behind the absence of the 
intestinal signature in these samples. We thus conclude that the intestinal/non-
intestinal molecular taxonomy is highly robust and reproducible across platforms and 
populations and that there clearly are at least two distinct molecular variants of 
gastric cancer.  
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 Figure 3.13: Presence of normal-gastric and intestinal signatures in malignant and 
non-malignant samples.  
 
The figure below shows all samples clustered with two gene groups viz. gastric enzymes and 
intestinal markers. The Dataset AU comprises of three non-malignant forms – Normals (N), 
Chronic Gastritis (CG) and Intestinal metaplasia (IM). Almost all the non-malignant samples 
have high expression of gastric enzymes with most of the IM samples showing high 
expression of both intestinal and gastric enzymes. The malignant samples with low 
expression of intestinal genes (red square) also have low expression of gastric genes thereby 
confirming absence of any contaminating normal tissue being present in the samples with 
low expression of intestinal markers.  The dataset SG and JP comprises of 3 and 8 normals 
respectively, with no group characterized by low expression of intestinal genes with high 
expression of gastric enzymes is observed. Finally for dataset HK, which comprised of 90 
malignant samples, a very small group of such samples was observed (5 samples). The 
majority of the samples do not have a high expression of the digestive enzyme group of 
genes. 
 
























3.6.8 Experimental Manipulation of the Wnt Signaling Pathway Affects 
PLA2G2A Expression 
We analyzed two public gene expression data sets described in the following reports:  
(A) Data Set 1: Sansom, O.J. et al. Loss of Apc in vivo immediately perturbs Wnt 
signaling, differentiation, and migration. Genes Dev 18, 1385-1390 (2004) 
(B) Data Set 2: van de Wetering, M. et al. The β-catenin/TCF-4 complex imposes a 
crypt progenitor phenotype on colorectal cancer cells. Cell 111, 240-250 
 
Data Set 1  
Brief description: Mice bearing a lox-flanked Apc allele were crossed into an inducible 
Cyp1A promoter-Cre transgenic background, where Cre expression can be induced in the 
intestine using the chemical β-napthoflavone. Nuclear localization of β-catenin, indicative of 
Wnt signaling activity, was observed on day 3 following intestinal recombination. Gene 
expression profiles of Cre induced Cre+Apcfl/fl tissues were generated using Affymetrix 
U74A and MOE430A Genechips.  
 
Analysis: The authors have listed in the Supplementary Information associated with this 
report (Supplementary Table 1, available at www.genesdev.org) a list of the top 100 genes 
upregulated at days 4 and 5 following Apc loss. An examination of this list reveals that 
PLA2G2A (Accession number X74266) is the second-highest ranked gene, showing an 
increase of 7.25 fold on day 5. PLA2G2A does not appear to be regulated on day 4 (1.02 
fold).  
 
Data Set 2 
Brief description: The colon carcinoma cell line Ls174T expresses a constitutively active 
mutant β-catenin protein. The authors established Ls174T cell lines carrying doxycycline-
inducible N-terminal truncated TCF transcription factors (dnTCF), which are dominant-
negative inhibitors of the endogenous β-catenin/TCF complexes in these cells. After dnTCF 
induction, gene expression profiles were established after 11 and 23 hr, using 24K cDNA 
microarrays, where the induced time points were labeled using Cy5 and the uninduced 
reference with Cy3.  
 
Analysis: The microarray data for this project is publicly available at the Stanford 
Microarray Database (SMD) at 
 http://genome-www5.stanford.edu/cgi-in/publication/viewPublication.pl?pub_no=191  
 
We queried this database for the PLA2G2A gene, represented by IMAGE clone 77915. The 




Data Retrieval Summary 
• Data Retrieval Options 
o Selected Result Sets (from experiment set Homo sapiens: Induction of 
dnTCF-4 in Ls174T CRC cells) 
- shu040 Tcf4-DN 11hr (default result set): weight 1 
- shr126 TcF4-DN 11hr (duplo) (default result set): weight 1 
- shu041 Tcf4-DN 23hr (default result set): weight 1 
- shr127a TcF4-DN 23hr (duplo) (default result set): weight 1 
o Gene Selection:  
- Control spots were not included. 
- Empty spots were not included. 
- IMAGE:77915 
o Data Collapse and Retrieval 
- Row data were retrieved and averaged by : LUID 
- UID column contains : NAME 
- Retrieved Log(base2) of R/G Normalized Ratio (Mean) 
o Data Filtering Options 
- Selected Data Filters: 
- Spot is not flagged by experimenter 
- No data filters selected for GENEPIX result sets 
- 1 luid(s) passed filters 
o Gene Filtering Options (iteration 1) 
- Data Distribution Filter: none selected 
- Data Transformation/Centering Options 
- No centering selected 
- Data Value-Based Filter: none selected 
- Data Quality (number of spots passing the spot filter criteria) 
- No data quality filters selected 
 
The gene expression values for PLA2G2A, on a log2 Cy5/Cy3 scale, are as follows:  






group IIA (platelets, 
synovial fluid) || 
Hs.466804 || T61271 || 
|| 5320 || 114857 
  -0.61 -0.68 -1.02
 
At the 23 hr time point, PLA2G2A is modestly repressed, from 1.6 to 2.0 (average 
1.8-fold). 
 
